LV10120B - Method of producing of new plasmides and using thereof in producing of the plasminogen activator - Google Patents

Method of producing of new plasmides and using thereof in producing of the plasminogen activator Download PDF

Info

Publication number
LV10120B
LV10120B LVP-92-204A LV920204A LV10120B LV 10120 B LV10120 B LV 10120B LV 920204 A LV920204 A LV 920204A LV 10120 B LV10120 B LV 10120B
Authority
LV
Latvia
Prior art keywords
rscu
plasmid
coli
pbf
plasmids
Prior art date
Application number
LVP-92-204A
Other languages
English (en)
Other versions
LV10120A (lv
Inventor
Regina E Brigelius-Flohe
Leopold Flohe
Wolfgang Hillen
Gerd J Steffens
Wolfgang Strassburger
Martin R F Wilhelm
Original Assignee
Gr Nenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gr Nenthal Gmbh filed Critical Gr Nenthal Gmbh
Publication of LV10120A publication Critical patent/LV10120A/lv
Publication of LV10120B publication Critical patent/LV10120B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Description

LV 10120
CnOCOB ΠΟΛΥΗΕΗΗΗ Η0ΒΗΧ nJIA3MHfl Η HX ΠΡΜΜΕΗΕΗΗΕ ΠΡΜ ΓΟΥΜΕΗΗΗ ΑΚΤΗΒΑΤΟΡΑ ΠΙΙΑ3ΜΜΗ0ΓΕΗΑ ΠρΗ ΤβρβΠΗΗ, 06yCJI0BJieHH0ft φΗβρΗΗΟΜ, 3aKynOPKM COCyflOB κβκ HanpuMep, ΗΗφερκτβ MHOKapjja, θμΟοληη λθγκηχ, apTepnaJii>HHX COCyAHCTbIX 3a(50^eBaHHK ΚΟΗβ«ΗΟΟΤβίί Η ap., βΚΤΗΒβΤΟΡΗ nJiaSMH-HoreHa nrpaioT cymecTBeHHyio pojib. C Ha«aJia 50-ux γολοβ H3BecT-ho, «το npeBpameHHe nJia3MHHoreHa odycjioBJieHO ero npeodpa30Ba-HH6M B nJia3MHH, Τ.θ. B 9H3HM, KOTOptlft 0(5yCJI0BJIHBaeT ρβΟΠΙβΠΛΘ-HH6 φΗ0ρΜΗ3 B paCTBOpHMHe ΠΘΠΤΜβΗ H, T3KHM O0pa3OM, paCTBOpe-ΗΗΘ 0(5yCJI0BJieHHUX φΗβρΗΗΟΜ ΤΡΟΜ^ΟΒ. 8ΤΟΤ βΚΤΗΒβΤΟΡ ΠΛ33ΜΗΗ0Γβ-Ha dbiJi HasBaH ypoKHHa3oft, h oita3a;iocb, «το b aeficTBHTejibHOCTH cymecTByK)T pa3Jin«Hbie Φορμη ypOKHHa3ti. Bce 3th Φορμη noJiy«aioT-cb ojiHHaKOBo, HenocpeACTBeHHo H3 oflHoK MOJieKyjiH-npeflmecTBeHHH-Iļbl, H3BeCTH0fi npH0JIH3HT6JIbHO C CepeflHHbl 70-ΒΙΧ ΓΟΛΟΒ, UHMOrena npoypoKHHa3H. Torjia tao ycTaHOBJieHO, «to 3Ta npoypoKHHa3a oOjiaflaeT oflHoueriHoft CTpyKTypofi h OHa dujia Ha3BaHa " scu-pa" (single Chain urinary plasminogen aktivator). 8Ta scu-PA COCTOHT M3 411 aMHHOKHCJIOT H rJIHK0JIH3HP0BaH B npHpOAHOft npea-uiecTByiomeM φορΜβ flo aMMHOKHCJiOTU 302. H3 pa3Jin«Hux padoT H3BecTHo reHOT6XHOJiorn«ecKoe nojiy«eHHe HerJIHK0JIH3Mp0BaHH0fi «aCTH ΠρΟΤβΗΗβ SCU-PA, KOTOpafl Ha3BaHa " rscu-PA” (peKOMOHHHpoBaHHafl scu-PA ) η ΜΜββτ Tanse TpnBnajitHoe Ha3BaHne "capynjia3a". Πρκ TepaneBTH«ecKOM Hcnojib30BaHHH rscu-PA OKa3ajiocb, «το ero HadJiroflaeMoe fleftcTBHe η οοβμθοτμμοοτβ πρβΒΟΟχοΛΗΤ ynoīpetoeMbie ΦηΟρηηολητηκη (cm. "JlaHiļeT", 1989r. ctp.863-868). ta nojiy«eHHH HerjinK03HJinpoBaHHoro aKTHBaTopa njia3MHHo-reHa rscu-PA ncnoJib30Ba;iH nponapMOTHTbi, ο «θμ yae cymecTBOBa- 2. •jih ΗθκοτορΗβ aaHHbie b jiHTepaType. Μ3βθοτηηθ flo HacTOHmero ΒρβΜβΗΜ cnocotfbi noJiyveHHH §cu-PA ocHOBaHu Ha 9Kcnpeccnn cTpy-KTypHoro reHa scu-PA BtmeJieHHoro H3 ve.noBevecKHX TKaHei*. K coaajieHHK), πρπ θτομ flocTuraeTCH JiHuib He3HavHTejibHafl οτθπθηβ 3Kcnpeccnn, KOTopan He odecnevHBaeT 3K0H0MHvecK0e nojiyveHHe uejieBoro npoayKTa b 6ojibiunx KOJiHvecTBax. TaK HanpHMep, οπη-caHHOe Hibino H flp. B "Agrie, Biol, Chem " 52, 329-336,1988, nojiyveHHe rscu-PA 6aKTepnH e.coū aaeT CTeneHb 3Kcnpeccnn jiHiiib 2%, H3MepeHHyio b oc5iu©m KOJin^ecTBe dejuca daKTepHfi. C iipy-roK ctopohh, b.eBponeftcKofi 3ΒΗΒΚΘ Ha naTeHT 92 182 A2, a TaKae Hoimec h flp. flocTHraeMyio CTeneHb aitcnpeccHH tovho He yKa3biBa-I0T. OflHaKO πρκ npOBepKe 3THX flaHHbIX B pa3JIHVHHX ΙΠΤΒΜΜΒΧ tfblJIO nojiyveHO MeHee 2% προτβΗΗβ daKTepnfi rscu-PA.
Cjie^oBajio 6u yita3aTb Ha to, vto b dojibīDHHCTBe c;iyvaeB 3KcnpeccHH 3yKapnoTHoro npoTeHHa b daKTepHHx nojiyvaeTCH Taitae rscu-PA b KJieTKe b KavecTBe fleHaTypHpoBaHHoro BKJiioveHHoro Te-jia, κοτοροθ flajiee Ha3HBaeTca "προτθηηομ npeflBapHTejibHOft οτθληη” kotopu^ noejie npoMeayTOWHoro BH^ejieHHH, λολβθη dbiTb προτθηηοχη-MHVeCKH B03BpameH K npaBHJIbHOH VeTBepTHVHOfl CTpyKType rscu-PA. nojiyqeHHbifi τβκμμ odpa30M npoflyKT mobho eaTeM πβρβΒβοτκ jņjra onpe flejieHHH o6pa30BaBiiierocH KOJiHvecTBa rscu-PA , HanpHMep, nodaB-λθηηθμ njiaeMHHa, b flByxuenHyio HerjinK03minpoBaHHyio ypoKHHa3y ("rtcu-PA^ 8Η3ΗΜΗ3Η dKTHBHOCTb KOTOpofl OnpefleJieHa Η MOaeT CJiy-anTb Mepofl o6pa30BaBUierocfl KOJiHvecTBa rscu -pa. ΕοτβοτΒβΗΗο, momho onpeaejiflTb βηχολ npoTeHHa npeflBapHTeJibHOft CTaflHH hjih rscu-PA h TaKHM o6pa30M, οτθπθηβ 3KcnpeccHH, HanpHMep, c πομο-mbio fleHCHTOMeTpHuecicofi οηθηκη γθλθβογο ΘΛβκτροφορβββ BCero ΠΡΟΤΘΗΗΒ.
HeoaH^aHHo dbiJio odHapyaeHo, ντο όβκτβρΗΗ, τρβΗΟφορΜπρο-BaHHbie nJia3MHflaMH, nOJiyveHHHMH B COOTBeTCTBHH C Η3Ο0ρβΤβΗΗβΜ, flaioT bo μηογο pa3 6ojibiuyK) CTeneHb siccnpeccHH, veM mTaMM-xo3HMH, HfleHTHVHO Τρ3ΗθφθρΜΜρθΒ3ΗΗΗΐί nJia3MHflaMH, Η3ΒβΟΤΗΜΜΗ H3 CnOCOČa ypOBHH ΤβΧΗΗΚΗ. flOJiyVeHHbie B COOTBeTCTBHH C Η3θ6ρβΤβΗΗβΜ njia3-MHflbl, B COOTBeTCTBHH C 3THM 6θΛββ ΠΡΗΓΟΛΗΗ, V6M BC6 Η3ΒβΟΤΗΗβ flo HacTonmero ΒρβΜβΗΗ n^a3MHAU, ajih nojiyveHHH rscu-PA hjih ero npoTeHHa npeAtuecTByiomeft CTaflHH. CjiejņyeT eme ynoMHHyTb, ντο H3-BecTHUM odpa30M MoaeT feb nojiyveH TaKae c noMombio y»e ynoMH- LV 10120 'HyToro Bbiuie ajih aHajiHTHtiecKHX uejiefl pacmenjieHHH rscu-PA, HanpHMep njia3MMH0M, TaK«e h rtcu-PA - b TexHHuecKHX MacuiTaOax, nOCJie uero, djiaroflapfl ΠρβΑΛΟΚΘΗΗΟΜγ H306peTeHHK),0WeHb flOCTy-ΠβΗ rscu-PA. f1Jia3MMJQbI, nOJiyWaeMbie B ΟΟΟΤΒΘΤΟΤΒΗΗ C Η300ρβΤβΗΗΘΜ, OT-jnmaioTCfl, κροΜβ τογο, τθμ, uto nx onepoH ΜΜββτ peryjiHpyeMbiK b cooTBeTCTByioiiieM cjiy*iae cHHTeTHuecKHft npoMOTOp, aKTHBHyio, b KauecTBe MecTa cbh3h phOocom, nocjieflOBaTejibHOCTb D]HHO-,najibrapHO, CTapTOBHfi KOflOH, ΟΗΗΤβΤΜ^βΟΚΗίί CTpyKTypHHfl γθη ρ,λη scu-pa h προτηβοπολοβηηΚ pacnojioaeHHio CTpyKTypHoro reHa, no Kpaitoefl μθ-pe, ο,αηη τβρΜΜΗβτορ. npeflnouTHTejibHO ΗΜβιοτ Μβοτο ολμη 3a flpy-γμμ cjieflyroiiiHe τβρΜΗΗβτορκ, b cjiytiae κοτορυχ peub Ηββτ b uacTHO-cth o trpa TepMHHaTope h/hjih o tet A/orfi TepMHHaTope H3 τη , CM. Schollmeier H flp. B cjiyyae peryjinpyeMoro npoMOTopa pe^b HfleT, b wacTH0CTn, o tac npoMOTope HJIH trp ΠΡΟΜΟΤΟΡΘ. B KOHTpOJIbHOM ρβΓΗΟΗβ nOJiyweHHbie B C00TB6TCTBHH C H30-dpeTeHHeM njia3MHflbi ημθιοτ paccTOHHHe Mew nocjieaoBaTejibHocTbio UJnHO-^aJībrapno h CTapTOBbiM ko,e(ohom 6-12, npe^no^iTHTeJibHo 8-10 HyKJieoTH,aoB. ΠρΗ KOHCTpynpOBaHHH HCn0JIb30BaHH0r0 B HOBbIX njia3MH,E(ax cTpyKTypHoro rēna npeflnouTHTejibHo BCTpaHBaioT 3aK0flnp0BaHHbie Ajih cooTBeTCTBywmnx aMHHOKHCJiOT npHBefleHHbie b cJieAjrouieii Ta6-Jiniļe 6a30Bbie nocjie/joBaTejibHOCTH. Πρκ θτομ b CTpyKTypHOM reHe He flOJIMHbl (5bITb ΒΗΠΟΛΗΘΗΗ ΟΛΗΟΒρβΜβΗΗΟ ΒΟβ 3TH ΟΤΛΗΊΗΤβΛbHUG ΠΡΗ3Η8ΚΗ. AMHHOKncjioTa: TpnnjieT:
βρΓΗΗΗΗ CGT JieftiļHij CTG BaJIHH GTT npOJIHH CCG rJIHUHH GGT C flpyroii cTopoHbi, πρκ ποοτροθηηη cTpyKTypHoro reHa nejie- C006pa3H0, ΠΟ B03M0BH0CTH, H30eBaTb ΠΡΜΜΘΗβΗΗΛ ΟΛΘ^ΙΟϋΙβΓΟ KO-flOHa flJIH COOTBeTCTByromHX Ηβ3Β8ΗΗΗΧ aMHHOKHCJiOT (npH^eM, CHOBa ΗΘ flOJIBHbl BbinOJIHHTbCH ΟΛΗΟΒρθΜβΗΗΟ 3TH OTJIH^HTeJIbHbie ΠΡΗ3Η3ΚΗ flJIH BC8X aMHHOKHCJiOT). 4.
Kohoh. κοτορογο cjienveT Amhhokmcjtota : H36eraTb:
ATA HaojiefliiHH
GTC BaJIHH
CCC npOJIHH
AAG JIH3HH AGG AGA, CGG, CGA ΑρΓΗΗΗΗ GGA, GGG ΓΛΗΙ^ΗΗ flyTeM Bufiopa KOAOHa, b οοοτβθτοτβηη c H30tfpeTeHneM, ajih οτββΛΒΗΗχ aMHHOKHCJioT b οτργκτγρΗΟΜ rene, a τβκκβ BbnneHa3BaHHbix OTJIHWHTeJIbHHX npH3HaK0B ΚΟΗΤΡΟΛΒΗΟΓΟ Γ8Η3, ΠΟΛΗΟΟΤΒΚ) ΠρβΠΗΤ-cTByioT o(5pa30BaHHio CTa0HJibHbix BTopnwHux cTpyKTyp Me*fly CTpyK-TypHUM Γ6Η0Μ H KOHTpOJIbHHM Ρ6ΓΜ0Η0Μ.
Ajih nojiytieHHH cHHTeTHuecKoro CTpyKTypHoro reHa CHanajia CHHT83HpyiOT OJIHrOHyKJieOTHJļbI B 0ΤΡΘ3ΚΘ 40-80 OCHOBaHHŪ B 0,UHy uenomcy. L(ejiecoo6pa3HO nojiyiiaTb hx b MacmTatfe 1 mkm/moji no Me-TOAy ΤΒβρΛΗΧ Φδ3 no AaaMcy h ap· c πομοπιβιο ,QHK-CHHTe3aTopa mo-AeJlH " Biosearc8600" φΗΡΜΗ "New Brunsevick Scient '·. B Ka^eCTBe ΜΟΗΟΜβρΗΟΓΟ CHHTOHa ΠΡΜΜβΗΗβΤΟΗ ΠΡΗ 3T0M HMeiOIHHfiCfl B ΠρΟΑβΚΘ β- IļHaH0-3THJI-3aMemeHHHe ΑΗΜ30ΠρθΠΜΛ8ΜΜΗΟ-φθθφθρθΜΗΑΗΤΗ οοοτβθτ-CTByiomHx Heo6xo,qnMbix fle30Kcnpn60HyKJie03Hfl0B, nocJie oTmeaneHHH ot H0CHT8JIH HaxoAflmnecH Ha KOHuax einē TpHTMJi3aMemeHHue hhth, OdeCCOJIHBaiOTCH 5 CTepHJIbHbIX yCJIOBHHX nyTeM ΓβΛΒφΗΛΒΤρβΙΙΗΙΙ M npeflBapuTejibHo otromaioTCH n, 3aTeM, β αβθ οτβΑΗΜ, noflBepraioTCfl nepBOMy pa3,qejieHHio c πομοιιιβκ) "B03BpaTH0fi φββΗ" -hplc. Οοοτβθτ-CTByromnfi οοηοβηοΑ npo^yKT fleTpnTHJinpyioT h, nocjie flByx*flonojiHH-Te;ibHbix CTaflHft o«hctkh "B03BpaTH0fi φ83Η''-ΗΡ^, nojiynaiOT uejieBofl OJIHrOHyKJieOTHfl BHCOKOft HHCTOTbl, KaK nOKa3aJI ΓβΛΒ3ΛβΚΤρθφθρβ3-Hblfl aHaJIH3 (page). H3 rpynnw 4-9 0thx οταθλβηηχ ημτθΒ nojiy«aJin 3aTeM ajihh-hoA okojio 200 HyKJieoTHflOB Φρβγμθητη αβοΑηηχ uenefi, WTo6bi He-KOHiļeBbie oTfleJibHue ojinroHyKJieoTHflH y δ/'-κοΗΐιβ φοοφορκΛκροΒβτΒ μ cooTBeTCTByK)mHe KOMnjieMeHTapHHe hhth βμθοτθ c κοηι4θβημη ojih-roHyKJieoTMflaMM AeHaTypHpoBaTb h JinrHpoBaTb. nocjie Jinrannn 00pa30BaBiiiHeci!, cnocofiHue κ κλοηηροββηηιο, flBoftHbie uenHue φρβΓ-M8HTbI HCnOJIb3yK)T 38T6M B ΠΟβΧΟΑΗΙΙΙΗΧ JIHHeapH3HpOBaHHbIX ΒΘΚΤΟ- pax. AonojiHUTejibHbie Mepbi mokho y3HaTb H3 HHKenpnBefleHHbix npn-MepoB. 5. LV 10120
Hcnojib3yeMbie b npefljīPaeHHofi 3aflBKe coitpameHHH ΚΜβιοτ cjieflyioiHHe 3HaweHna: pu - Piong untis 6n - ocHOBHbie napu ŪE 52 - aHHOHOOŪMSHHMK φΐφΜΗ E.HTK - 3THJieHflnaMHHOT0TpayKcycHafl KHCJiOTa ΜΠΤΓ - H30nponMJI- - -TH0raJiaKT0nHpaH03Hfl PAGE - Π0ΛΗβΚΡΗΛβΜΗΛΓΘΛΒ3ΛΘΚΤΡ0φ0ρβ3 HflC - HaTpHMflOfleunjicyjib$aT
DI.’H.nocjieflOBaTejibHOCTb - ūlHHe-JlajībrapHO-nocjieflOBaTejibHOCTb TpHC- fjtt - mflpoXJIOPHfl TPHCrHflpOKCHMeTHJiaMHHOMeTaHa TBHH-80 - nOJIH9THJI0HOKCHfl COpdHTaHMOHOOJieaT JļJIfl KOHCTpyHpOBaHHH, B C00TB8TCTBMH C Η3θ6ρβΤΘΗΗΘΜ, HO- bux iuia3MHA npeflno^iTHTejibHO ηοχοαητ ot HMeiomeficfl b npoflase nJia3MHfltI pBR (4363 tfn). ΠρΘΛΠΟ^ίΤΗΤβΛΒΗό H3 H66 3JIHMHHHpyK)T nic/bom O&iaCTb H/HJIH TeTpaiļHKJIHHOBblfi pe3HCTeHTHHft Γ6Η. ΠρΗ 3T0M ΗβΤ Heo6XOJD[HMOCTH nOJIHOCTbfO tfījaJIHTb ΓβΗ ρβ3Η0ΤβΗΤΗ00ΤΗ κ TeTpaqnKJiMHy, wame Bcero AOCTaTOUHO, wto6u ruia3MHfla ηθ nepe-Aajia TpaHC®opMnpoBaHHOMy t3khm otfpa30M QiTdMMy δβκτθρκβ ycTofi-IIHBOCTM K TeTpaUHKJIHHy. C nOMOmbK) 3ΤΗΧ Mep (yflaJieHHe nic/bom o^JiacTH h uacTH reHa ρβ3ΗοτβΗΤΗθοτΗ κ TeTpaijMKJiHHy) nojiyuaioT τβκ Ha3UBaeMyx) "BucoKOHaflesHyio njia3MHfly". npeflnowTHTejibHO0 CTpaTerne8 fljia KOHCTpynpoBaHMfl hoboR n^a3MHflbI, B C00TB3TCTBHH C Η300ρβΤβΗΗΘΜ, HCXOAfl H3 ΜΟΑϋφΗΑΗρΟ-BaHHoK, κβκ yriOMHHaJiocb BHme, njia3MHAti pbr322 (hjih flpyrofl Ha3-BaHHofi, H3BecTHoK paHee, njia3MWAbi) ηβληθτοη, b Ka^ecTBe nocjie-flyiomefi CTaflHH, βοτρβηββηηθ ομητθτμ^θοκογο "caflTa MyjibTHKJioHnpo-BaHHH" Meafly m@ctom pa3pe3a eco ri m Hind m#. 8tot cafiT My;ib-THKJIOHHpOBaHHH ΗΜΘβΤ yCTaHOBJieHHyiO nOCJieAOBaTeJIbHOCTb MeCT pa3pe3a, Jieiaume μθβαυ Himh ocHOBaHHH ηβληιοτοη npoH3BOJibHO bh-OpaHHHMM, 3a ΗΟωίΧΝΘΗΗΘΜ nOCJieAOBaTeJIbHOCTH Me»Ay Xbal M NdeI, KOToptie coAepiaT Μβοτβ cbh3h pmGocom (UlHHe-AajībrapHo-nocjieAOBa-TejibHOCTb) H3 xyi-onepoHa 5'-aaggag -3'(4)B.subtilis , a Tanae ycTaHOBJi6HHoro pacTOHHHH Me«fly UI.A.-nocJieflOBaTejibHOCTbio h CTap-tobum KOflOHOMatg . Cjieflyiomne 3a ID.A.-noc^eflOBaTejibHOCTbK) ocho- ΒβΗΗΗ GAAAT ΠβρβΗΘΟβΗΜ M cBfl3aHH C CATATG , ΜΘΟΤΟΜ JDa3pe3a NdeI TaKHM odpa30M, paccTOHHHe Me«fly III.A.-nocjieflOBaTejibHocTbKī h atg cocTaBJiaeT 8 οοηοβημχ nap. PaccTOHHMfl Me»fly οταθλβηημη μθοτβμη 6. •pa3pe3a caītoa Myjibthkjiοηηροββηηη hojikhh 6ητβ , H3 cootfpaaeHHi* TeXHOJIOrHH KJIOHHpOBaHHH, ΠΟ ΜβΗΒΠΙβΑ Μβρβ OKOJIO 20 HyKJieOTHflOB f b pe3yjibTaTe wero ofaeniaeTCH yflajieHHe npoMe»yTOWHbix «fcparMeHTOB. C nOMOUlbK) 3Τ0Γ0 CafiTa MyJIbTHKJIOHMpOBaHHfl B nJia3MHfly BBO-flHT MecTa paepesa, KOTopue, nocjie BCTpāHBaHHH TepMHHaTopa Tpan-cKpnniJ[nn, fleJiaioT βο3μομηημ c;ieflyiomee npyr 3a apyroM ycneuiHoe BCTpaMBaHHe «acTHtiHoft nocjienoBaTejibHOCTH scu-pa cTpyKTypHoro rēna, npe,EtnowTHTejibHO HaunHaromerocfi ot C-KOHua uejieBoro npoTeHHa, T.e. ot 3'-KOHua ηητη HHK nojijroaiomerocfl CTpyKTypHoro reHa, a TaK «e BCTpanBaHHH, HanpHMep, οηητθτηιιθοκογο, hjih TaK*e BbmejieHHoro H3 apyrofl njiasMHflH, hjih KMeiomerocfl b npoflaae trp -npOMOTOpa. nojiHaB HyKJieoTH,qHafl nocjienoBaTejibHOCTb nojiy*ieHHoro TaKHM otfpaeoM scu-pa -CTpyKTypHoro reHa npeflCTaBJieHa c yKa3amieM aMHHOKHCJioT , COOTBeTCTByiOmHX OTfleJIbHOMy KOflOHy. ,Qpyrne ηοβηθ njia3MHflbi MoryT (5ητβ nojiyyeHH,B οοοτβθτοτβηη c H3o6peTeHHeM, H3 CKOHCTpyHpoBaHHofl KaK onHcaHO Bbiine njia3MHflbi, HanpHMep, nyīeM pa3pe3a c noMombio Eco ri h Hind iii nojiywaK>T CHHTeTH^ecKHii scu-PA-CTpyKTypHHK reH co βοθμη θληηηιιβμη peryjin-poBaHHH h, eaTeM, BCTpanBaioT b flpyryio, b 9HTepo0aKTepH8HyK>, b
UaCTHOCTH,E. coli, aBTOHOMHO MHO»amyiOCH nJia3MHfly, KOTOpyiO K TO-My .«e JiHHeapn3HpyiOT hjih yKopawHBaioT c noMombio paspe3a c πομο- mbK) ECO RI H Hind III. TaKHM »β, B ΠΡΗΗΙίΗΠβ, ΟΠΟΟθ6θΜ, HO ΠΡΗ Hcnojib30BaHHH MecTa paepesa eco ri h xba mokho 3βμθηητβ Tanie, HanpHMep trp -ΠΡΟΜΟΤΟΡ tac -ΠΡΟΜΟΤΟΡΟΜ H HaO^OpOT B nOJiytieHHOfi B COOTBeTCTBHH C Η3θ6ρβΤβΗΗβΜ nJia3MHfle. AHaJIOrHHHO MOHHO HCXOflHTb ΤβΚΚβ H3 flpyrHX Η3ΒβΟΤΗΗΧ njia3-μηλ, κοτορΗβ o^JianaioT eflHHCTBeHHbiM ΜβοτοΜ pa3pe3a.
HoBbie njia3MHflbi c yBejiHweHHUM paco'TOHHHeM Meamy IIIhho-.HajībrapHo-nocjieflOBaTejibHocTbio h CTapTOBUM koaohom ATC moikho nOJiyUHTb,B COOTBeTCTBHH C Η3θ6ρβΤ6ΗΗβΜ, ΤβΜ, MTO CKOHCTpyHpO-BaHHaH^ KaK onncaHo Bbime njiasMHfla, b κοτοροβ ynoMHHyToe paccTO-HHHe cocTaBJineT, HanpHMep, 8 HyKJieoTH(qoB, pa3pe3aiOT Nde ι, ko-Topoe 3anojiHHeT nojijreeHHoe Μβοτο paepesa h, HenocpencTBeHHO nocjie 3Toro, nojiyueHHue kohiih JiHrHpyioT, b pe3yjibTaTe wero 06-pa3yeTCH KejiaeMan HOBan njia3MHfla, b κοτοροΑ paccTOHHHe Me»,Eļy Ul.il.-nocjieflOBaTejibHOCTbK) h CTapTOBbiM κολοηομ cocTaBJineT, HanpHMep, 10 HyKJieoTHflOB. LV 10120 7.
KaK yae tao 0Ka3aH0, c ΰβκτβρΗΗΜΗ, τρ3ηοΦορμηροββηηημη nJia3MHflaMH, nOJiyueHHbIMH B COOTBGTCTBHH C H306pGTGHHGM, MOKGT 6biTb j[0CTnrHyTa bo μηογο pa3 fojibinan οτθπθηβ 3KcnpeccHH, ueM b cjiyuaflx Η3Βθοτηηχ H3 ypoBHH τθχηηκη njia3MH,q. ΤρβΗοφορΜβρΗΐο nOflXOflHmHX ΚΟΜΠβΤβΗΤΗΗΧ 0ρΓ3ΗΗ3Μ0Β-Χ03ΗβΒ OCymeCTBJIflK)T Η3ΒβΟΤ-hhm o<5pa30M. Hjih aKcnpeccHH, noJiyyeHHHX b οοοτβθτοτβηη c H30-όρβτβΗΜβΜ, njia3MHfl οοο6θηηο πρηγοαηη opraHH3Mbi mTaMMa-xo3HHHa THna E.coli Η Λρ.ΠρΗΜβΗΗβΜΗβ 3ΗΤβρ00βΚΤβρΗΗ,Κ3Κ HanpHMep, UITaM-Mbl Pseudomonas, Salmonella, Enterobacteria, Klebsiella, Serratia. ΠρβΑΠΟ^ΤΗΤβΛΒΗΗΜΗ 0praHH3MaMH-X03fleBaMH HBJIflIOTCH MTaMMH THna E.coli , ΚβΚ ΗβΠΡΜΜβρ,Ε. COli GRT-1 Η, B tiaCTHOCTH, ΙΠΤ3ΜΜΗ e. coiinonrpynnbi K12, KaK HanpHMep, E.coli K12y M101/ATCC 33876/, E.coli K12 y M103/ATCC 39403/, E.coli K12 y M105/dsm4162/, E.coli K12 ATCC 31446 hjih TaKKe E.coli K12 dni/ATCC 33849/. ΒβΘΛΘΗΗΘ 3KCnpeCCHH B 3KCnpeCCHOHHyiO CHCTeMy E.coli, ko-Topan οολθρκητ tac-προΜθτορ, mokho ocymecTBJiHTb, HanpHMep, nyTaM flodaBJieHHH JiaKT03bi hjih oidopa rjnoK03bi, ho πρθλπο^τητθλβ-ho nyTeM «ņodaBJieHKH H3onponHJi-a-D -THorajiaKTonnpaH03Hfla. OflHa-ko, ecjin b njia3MMfle ημθθτοη trp-προΜθτορ, to HHflyKijHio ocymecT- BJIHiOT npeMMyiHeCTBeHHO C nOMOUlblO HHflOJiaKPHJiyKCyCHOfi HJIH HHflOJI-aKpHJi-nponnoHOBoii KHCJioTbi. HpyrHe H3BecTHbie HHflyKTopbi, caMO codo8 pa3yMeeTCH, MoryT tob TaK»e Hcnojib30BaHbi.
flocjie hhotuhh h nocTH«eHHH onpeflejieHHofi BbiiiieyKa3aHH0ft IIJIOTHOCTH KJieTKH, KJieTKH OTUeJIHIOT ^eHτpHφyΓHpoBaHHeM H OCTa-tok, nocjie ^eHτpHφyΓHpoBaHHfl, nocjie cycneH3HpoBaHHH β βοληομ COJieBOM paCTBOpe, ΠβρβΒΟΑΗΤ β Γ0Μ0ΓβΗΗ3βΤ0ρ, B KOTOPOM KJieTKH b pe3yjibTaTe pa3HHqa nasjieHHH πολβο,ιιητ k MecTy. nocjie ηοβογο ^eHτpHφyΓHpoBaHHH noJiywaiOT β οοτβτκβ προτβΗΗ npeflBapHTeJibHofi CTaflHH rscu-PA Hapflfly C BOflOHepaCTBOpHMbtMH O6JI0MK3MH KJieTOK H πρ. B pe3yjibTaTe otfpafiOTKH pacTBOpOM ryaHHflHHB προτβΗΗ npeflBa-pHTejibHoK CTaflHH πβρβχοβΗτ b pacTBop h, nocjie ηοβογο ^eHτpHφy-ΓΗρθΒ3ΗΗΗ, OTCTOHBUIHftCH paCTBOp 0<5pa(5aTbIBaK)T ρβΛΟΚΟ-ΟΗΟΤβΜΟΚ (HanpHMep, coflepiKaineii BoccTaHOBJieHHbift hjih OKHCJieHHbifi rjiyTaTH-οη), β pe3yjibTaTe wero ocyinecTBJiHeTca odpa30BaHHe βοτβοτεβΗΗοίί ΚΟΗφθρΜ3Ι1ΗΗ, Τ.β., 06pa30B3HHe IļeJieBOfi rscu-PA. OHa HaXOflHTCfl 3aTeM B peaKIJHOHHOfi CM6CH B paCTBOpeHHOii φορΜβ Η ΜΟΚβΤ 6bITb BbiflejieHa b mhctom BHfle b pe3yjibTaTe o6uuhux CTaunft o^hctkh, HanpHMep, ΧΡ0Μ3Τ0ΓΡ3φΗΗ H nOCJie^IOUierO BbICyilIHBaHHfl 3aM0pa»H- 8. Β8ΗΗ6Μ.
Mjih aHajiMTHtiecKnx uejiefi uejiecoo(5pa3Ho φβρΜβΗΤΗροΒβτΒ TpaHC$opMMpoBaHHufi noAJieKamefi HccjieAOBaHH» njiašMHAofi οιτβμμ E. coii h, nocjie αοοτημθηηη BbruieyKa3aHH0ft onTHMajībHOfi πλοτηο-CTH CycneH3HH, ΚΛβΤΚΗ HHflyiiHpOBaTb ΠΟΛΧΟΛΗΠΙΗΜ HHflyKTOpOM 3K-cnpeccHio rscu-PA - npoTeHHa npeABapHTejibHofi ctbahh. flocjie coot-BeTCTByiomeži npoAOJiKHTejibHocTH φβρΜβΗΤθρΗΗ oTtfnpaioT ajiHKBOTHbie yaCTH, H OT^eHTpHφyΓHpOBaHHMe H3 ΗΗΧ ĶJieTKH paCTBOpHIOT 38ΤΘΜ JĪH30IIHM0M (1 ΜΓ JIH30IļHMa Ηβ 50 MJI MMOJI ^Φβρ8 TpHCrHflP0XJI0PHHa c pH 8,0, 50 mmoji 3THJieHflHaMHHT©TpayKcycH0fi khcjiotoK h 15¾ caxap03bl). TOMOreHaT JIH3HpOBaHHbIX KJI6T0K CTa0HJIH3HpyiOT B 4-5 moji pacTBopa ryaHHAHHrHAPoxjiopHAa h nocjie pastfaBJieHHH ao 1,2 MOJI ryaHHflMHrHflpOXJIOpH,Iia ripu AOtfaBJieHHfl BOCCTaHOBHTeJIbHOro cpe-IlCTBa (rjiyTaTnoHa, MepKanToaTaHOJia hjih rHCTeHHa) 3a 2-5 uacoB noflBepratoT pBaic^UHH 0(5paTH08 (cm. TaKKe , HanpHMep, BHHKJiep h Ap.). nojiyyeHHyio tskum 0(5pa30M OAHoqenHyio rscu-PA npn AodaBJie-hm njia3MHflH npeBpainaioT b AByxHHTeByio rscu-PA, βκτηβηοοτβ ko-τοροΑ onpeflejiHeTCH c πομοπιβϊο cy6cTpaTa s 2444 (nHporJno-PJiH-Apr-n-HMTpoaHHJiHA; Ka0H-AHarHOCTHKa,(IlBeiJ[Hfl), KOTopuft OTiuenjineT-Cfl TOJIbKO OT AByXHHTeBOfi ypOKHH83bI. 8TO aKTHBHpOBaHHe rscu-PA njia3MHH0M ocymecTBJiHiOT b 50 mmoji Tpnc-dy®epe, 12 mmoji xjiophcto-ro HaTpHH, 0,02¾ TBHHa-80 npn pH - 7,4 h 37°C. CooTHOineHHe rscu-PA K njia3MHHy AOJIKHO COCTaBAflTb npH6AH3KTeJIbHO 100-1500 : 1, cwraH Ha MOJinpHOCTb hjih, npH0JiH3HTejibH0, 8.000-36.000:1 c^HTan Ha 3H3HMHyio @AHHHuy. TecTOByio HHKy0aiļHK) προβοαητ b 500 mmoji Tpnc<Sy®epa, 38 mmoji xjiopHCToro η8τρηη πρκ pH 8,8 b npncyT-CTBHH 0,36 MKMMOJI anpOTHHHHa (AJIH ΤΟΡΜΟΚΘΗΗΗ nJia3MHHa) H 0,27 mmoji 5 2444 npn 37°C. B 33βηοημοοτη OT coAepmaHHH npodH rscu-PA peaKUHio nocjie 5-60 MHHyTHOfl HHKy6aiiHH ocTaHaBJiHBaioT nyTeM ao-6aBJieHHH 90%-ηο8 yKcycHofi khcjioth η η3μθρηιοτ oKcnpeccnro npn 405 hm. Π^ο yKa33HHK3 H3roTOBHTejiH cydcTpaTa s 2444, b cjiyuae 3τοίί npeABapHTejibHOfi CTaAHH Η3ΜβΗβΗΗβ 3KCTHHKUHH 03HayaeT 0,05 Ha MHHyTy πρκ 405 hm 8kthbhocth 25pu /mji τθοτοβογο pacTBopa.
KaK BHAHO H3 ΗΗΚβΠρΗΒβΑβΗΗΜΧ ΠΡΗΜβρΟΒ, B W8CTH0CTH Ta6-jiHiļbi 1 npMMepa 2, πλ83μηαμ, noJiyuaeMbie b σοοτΒβτοτΒΗΗ c H3o6pe-ΤβΗΜβΜ , OCymeCTBJIHK)T npeAnOMTHTeJIbHO B IDT8MM8X E.COli00pa30Ba-ΗΗΘ rscu-PA npoTenHa npeABapHTeJibHoii ctbahh co CTeneHbH) 3Kcnpec- LV 10120 9. cm ot 10 flo 25 Bec. προυβΗΤΟΒ, b uacTHOCTH, 14-20 Beo·.* odpa-30BaBuierocH odiiiero προτβΗΗβ. Οτθπθηβ 3Kcnpeccnn, cjienoBaTejibHo, npH ΠρΗΜβΗβΗΗΗ ΗΟΒΗΧ nJia3MHfl# ΜΟΚβΤ dblTb flOCTHrHyTa, ΠΟ ΚρβίΐΗθΚ Mepe, β 10-15 pa3 Bbinie, ueM b cjiytiae η3βθοτηηχ nJia3MHA, Kax Ha-ΠρΗΜβρ,ρϋΚ 54 trp 207-1.
PeaKUHOHHHe οηοτθμη, πρημθηηθμηθ b npnMepax Ha ocyuiecT-BJieHMe cnocoda, hbjihiotch ynoTpedHTeJiBHbiMH, ημθιοπιημηοη b npona-Μβ (CM.HanpHMep Nachr.Chem.Techn.Lab. 35, 939, 1987).
Hcnojib3yeMaH b npHMepax hjih cejieKijHH kjiohob KyjiBTypHafl cpe^a coflepKHT Ha jihtp: 7,8 γ nenTOHa H3 pudu, 7,8 r nenTOHa hs Ka3eHHa, 10 r λρομθβογο aKCTpaKTa, 5,6 r, xjiopncToro HaTpHH, 10 r γλκ)Κ03η. 9Ty cpei[y cMeuiHBaioT c 10 r arapa Ha jihtp b Tenjie H BHJIHBaiOT Ha nJiaCTHHH. ΠΡΚΜΕΡ 1. K0HCTpyHp0BaHH6 3KCnp8CCH0HH0ft nJia3MHflM pBF 160 flJIH npo-ΤβΗΗΒ npe^BapHTeJIbHOft CTaflHH rscu-PA C CHHT6THU6CKHM scu-PA-reHOM npw KOHTpojie trp-npoMOTopa. a) KoHCTpyHPQBaHH8 njia3MHūbi pbf 158. I) H3 ruia3MHflHpBR 322 (SapMauefl, iP 27-4902, 4363 dn) Bbipe3ai0T nic-bom -odJiaCTb, KOTOpaH ΗβΧΟβΗΤΟΗ M8Kfly OCHOBaHHHMH h2263, y,ijajiHF0T Kan cJiefiyeT HH*e: pbr 322 y οοηοββηηη 2298 c Hfle 1 h t3khm odpa30M JiHHeapH3HpyioT. BucTynaioiHHe kohuh HanoJiHH-k)t nyīeM peaKUHH ."3anojiHeHHfl", h tbkhm odpa30M nojiytiaf0T Tynwe KOHLļbi pBR 322. nocjie 3τογο y οοηοββηηη 2063 pa3pe3aioT c πομοπιβιο Pvu 11 h oda Tynbix KOHija ocTaBmeficfl nacTH pbr 322 c πομοπιβιο OdbHJHOft ΤβΧΗΗΚΗ CH0B3 JiHrHpyioT c ΠΟΜΟΠΙΒΙΟ T4-JiHra3bi. HenocpejiCT-ΒΘΗΗΟ nocjie 3Τ0Γ0 JIHraiļHOHHafl BCTBBKa B COOTBeTCTByiOIIIHX E.coli 12 y M 103 KJieTKax (ATCC 39403) τpaHcφopMHpyeτcH. TpaHC(£opMHpo-BaHHbie KJieTKH KyjibTHBHpyioT Ha cpene npH aodaBJieHHH 150 jfr aMnn-UHJiJiHHa/MJi. H3 nojiyweHHbix kjiohob BbīdHpaioT TaKHe, κοτορΗβ coflep-ataT njia3MH,ay pbf 157, KOTopan OTJiHMaeTCH ot ηοχο,ιιηο8 njia3MHflbi pBF 322 Ha 228 HyKJieOTHflOB a) Pst 1 X BspM Iļ,d)Pst lxBal 1-, B) Pst lx Ava Ι-φρΒΓΜβΗΤΗ. Oda β,ΙΙΗΗΟΤΒβΗΗΗΧ ΜβΟΤβ pa3pe3a Pvu II h Nde l pbr 322 dojiee He coflepiaTCH b njia3MH,qe PBR 157. II) H3 pBR 157 y,aajiHioT dojibmyio uacTB TeTpauHKJiHHOBofl no-cjieflOBHTejibHOCTH ny?eM pa3pe3a c πομοπιβιο eco rv χ Nru 1 h no-cJie<iiyK)uieii Jīnraunefi ποηβηβπιηχοη Tynux kohuob. nocjie τρΒκοφορΜβ- iIHH E.coli K 12 y M 103 h Kyjiβτηβηροββηηη Ha cpene co 150>ir aMnHUHJuiHHa /mji^ nojiywaioT kjiohh, H3 κοτορυχ BbīdnpaioT τβ, κοτορυβ 10'. coflepaaT ruia3MHAy pBF 158. OHa Ha 787 HyiuieoTHAOB Kopotie, ueM pBF 157 h oTJiHuaeTca, κροΜβ τογο, OTcyTCTBHeM MecTa pa3pesa Bam HI. ΤρβΗΟφορΜβΙίΗΑ ΙϋΤΒΜΜΟΒ daKTepnfl C ĪIOMODlblO PBE 158 ΗΘ npHflaeT hm ρθ3ηοτθητηοοτη k T6TpaiļMKJiHHy. Λ b) KoHCTpyHPQBaHH6 pBF 158-01. BB&ūeHKe CHHTeTHgecKoro MyjibTMKJioHtipyK)iiiero oaflTa; H3 pBF 158 nyTeM pa3pe3a c noMOUtbio eco ri x Hind iii yflajiHioT φρβΓΜβΗΤ·, ' βθλη*ιηηοΑ 31 HyKJieoTHA h b jiiok jiHmpyioT chh-TeTiraecKHfl caftT MyjibTHKJioHnpoBaHHH. nocjie TpaHC<£opMauMH Jinra-UHOHHOfi BCTRBKH B E.coli K 12 y M 103 W KyJIbTHBHpOBaHHfl Ha epe-Αβ co 150 ja? aMnuLinjuiHHa/MJi BudHpaioT τβ kjiohh, κοτορκβ coAep-aaT njia3MHAy pbf 158-01. OHa oTJimiaeTCH ot pbf 158 AonojiHMTejib-HblMH MeCTaMH pa3pe3a Xba l,Nde 1, Sal 1, Eag 1, Kpnl,Spl I, a TaK«e βτορημ μθοτομ pa3pe3a Pst i. C) KOHCTPyHPOBaHHe PBF 158-01 T. ΒΒΘ,ΠβΗΜβ TPaHCKPHnUHOH-Horo TepMHHaTopa. M3 pBF 158-01 yAajiflK)T φρβΓΜβΗΤ cia ι χ Hind nicafiTa Myjib-THKJIOHHpOBaHHfl H 33ΜΘΗΗΚ)Τ Cla I X Hind ΙΙΙφρβΓΜβΗΤΟΜ H3PRT 61 (5), Ha KOTOPOM HaXOAHTCfl tet A/orf L TepMHHaTOp M3Tn 10(6.) flOCJie ΤΡ3Η0φ0ρΜ811ΜΜ B ΙΙΙΤβΜΜΘ E. coli K 12 y 103 H KyJIbTH-BHpOBaHHH Ha CPβΑβ CO 150 ΜΓ aMriHIiHJIJIHHa/MJI BUdHpaJIH Te KJIOHH, κοτορΗθ coAepsajiH ruia3MHAy pbf 158-01 T. OHa OTJiimaeTCfl ot pbf 158-01 φρ3ΓΜβΗΤ0Μ* cia I X Hind III tfOJIbllIMM Ha 297 HyKJieOTMAOB. d ) Ββθαθηκθ οηητθτη^θοκογο čparMeHTa M4 - M8 jjih scu-pa-reHa. KOHCTpyKUHH nJia3MHfl pbf 158-02 T - pbf 158-06 T,
Bce CHHTeTHgecKHe Φρβγμθητη omicaHH. Ohh bboahtch b coot-B6TCTByiomHe βθκτορη b KauecTBe npndJiH3WTejibHo αβοΒηηχ mivthko- ΒΗΧ φρ3ΓΜΘΗΤ0Β AJIHHOH 200 HyKJieOTHAOB. 3Τ0Γ0 ΒβΚΤΟΡΗ pa3pe- 3aK)T OCTaTOgHbIMH 3Η3ΜΜ3ΜΗ, COOTBeTCTByramHMH Η33Β3ΗΗΗΜ MeCTBM pa3pe3a, h, c noMombio 3;ΐθκτροφορθ3β Ha arapnoM rejie, 3JieKTpo-3JitonpoBaHHH h o^ihctkh, OTAeJiflioT uepe3 AE 52 ot noAAeaamero yAajieHH!o φρ3ΓΜβΗΤ3. flocjie θτογο ocymecTBJiHK>T jmmpoBBaHHe otho-CHUļHMCfl K He'My ΟΗΗΤΘΤΙΙ^ίβΟΚΗΜ φρβΓΜβΗΤΟΜ ΑΒΟΚΗΟίί Lienu C nOMOIflbK) T4-JlHTa3U, ΤΡ3ΗθφθρΜ3ΑΜΜ B E.coli K 12 y M 103 H CeJieKUHH Ha cpeAe, coAepsameft aMnnqnjuinH. LV 10120 11. I) ·ΠμγΗΡ0Β8ΗΜΘ ΦΡβΓΜΘΗΤβ Μ 8 ΜΘΒϋν BflM Η1 Μ Cla 1 Β njia3MMny pBF 158-01 Τ. noJiyqaeTCH ruia3MHfla pbf 158-02 Τ.
OjinroHyKJieoTHfl 019 KOflnpyeT fljia C-TepMHHajībHofi nocjieito-BaTejibHOCTH scu-pa. 3a οτοπ-κοαοηομ TAA HaxoflHTCH mocto pa3pe-3a Nhe 1, pacnpocpaHHiomeecH οτ λοπολημτθλβηοΚ nocJienoBaTejibHO-CTH TpaHCKpHnUHOHHOft trpa- TepMHHaTOpa (8) flO Cla l. II) JInrHPOBaHMe āpaPMeHTa M 7 Meamy spi 1 h BaM H1 b njia3MMgy pbf 158-02 T. noJiyHaeTCH nJia3MHfla pbf 158-03 T. III) JlHrnpQBaHne čparMeHTa M 6 Me«jy κρη 1 vt spi I b njia3MHiiy pbf 158-04 T. noJiywaeTCH njia3MHfla pbf 158-04 T. IV) ,)ΐΜΓκροΒ3ΗΜβ ČparMeHTa M 5 Me«gy Eag ļ η κρη I b njia3MMjiy pbf 158-04 T. nojiyyaeTCH njia3MWfla pbf 158-05 T. V) JInrannH d)parMeHTa M4 Meamy sai I h Eag I b njia3MHay pbf 158-05 T. nojiywaeTCH njia3Mw,na pbf 158-06 T. H3 nOJiyiieHHHX KJIOHOB i-V BN(5npaK)T ΟΟΟΤΒΘΤΟΤΒΘΗΗΟ Te, KO-Topue OT^HuaioTCH οτ cooTBeTCTByiomero npefluiecTBeHHHKa HamraneM BBeneHHoro ηοβογο $parMeHTa b flonojiHHTejitHO npoBepeHHofi npa-BHJIbHOfi nOCJieflOBaTeJIbHOCTH. e) BBe,qeHne οηητθτιμθοκμχ Φρβγμθητοβ M2 η M3 jjjih scu-pa--reHa. KoHCTpynpoBaHne pbf 158-08 T.
TaK κβκ fljia. BBeaeHHH Φρθγμθητοβ M2 η M3 ΗβοδχοΛΗΜ ποτ-Ι pa3pe3 h Ha ncnojib3yeMoft ajih θτογο njia3MHfle pbf 158 HaxonHTCfl eme Pst-I MecTO pa3pe3a (β aMmmHJiJiHHOBOft nocJieflOBaTejibHocTH), κοτοροθ Meuiajio 6b\ ripu nocjieflyiomeM KJiOHHpOBaHHH, nocTynaraT cjie-li;yiomnM o(5pa30M: I) M3 MMeiometo b npoflaae (HanpuMep, "Pharmacia") njiasMH-flbi ynajiHF0T cafiT MyjibTHKJiOHnpoBaHHfl h nonojiHHTeJibHO 212 Hyiuieo-thaob ββθρχ οτ Nde I x Hind iii φρ3ΓΜθΗΤ3. B nojiyueHHOM nponyc-Ke 3'βΤβΜ JIHrnpyiOT ΟΗΗΤΘΤΗίΣΘΟΚΚΑ CaŪT MyJIbTHKJIOHMpOBaHHH H3 nJia3MHflb! pBF 158-04-3 T B BHfle Nde-I X Hind III -φρβΓΜβΗΤβ. 8īy njia3MHfly pBF 158-04-3 T nojiywaiOT H3 πλβ3μηλη pbf 158-02 T (cm. npHMep īdi ) nyTeM BBeneHHH oJinroHyKJieoTHflHoro φρβΓΜθΗΤΒ M6 h cooTBeTCTBeHHO njia3MM,iīy pBF 158-04 τ 6e3 φρβΓΜβΗτβ M7, noCJie ΤΡ3ΗθφθρΜ31(ΗΜ B E.coli K 12 y M 103 KJieTOK H KyjībTHBHpO-BaHHH Ha cpene co 150 jfr aMnnqHjuinH/MJi BuduparoT τβ κλοηη,κοτο-Pbie conep*aT njia3MHfly pBF 158-03 -3 . Ohk OTJiimaiOTca HajiimH- 12. eM φρβΓΜβΗτβ Nde I χ Hind iii ajihhoK 712 HjrKjieoTHAOB. II) H3 $parM6HTa Pst I χ sac I βηλθληιοτ JiHHeapH3HpoBaHHHfi Ββκτορ h JinrnpyiOT oji«roHyKJieoTHAHHii φρβΓΜβΗΤ M3. nocjie TpaHC-φΟρΜβυΜΗ B E.coli K 12 y M 103 W KyJIbTHBHpOBaHHfl wa cpefle co 150 jav aMnHLļHJUlHHa/MJi, BuCupaiOT τβ kjiohh, κοτορΗβ coaepaaT ruia3-MHfly. Ona oTJin^aeTCH Φρθγμθητομ Pstl χ Sac I ajihhoA 189 HyKJie-oTHflOB, KOTOpufi coflepiHHT φρβΓΜΘΗΤ M3 c npaBHJībHoK nocjieflOBaTejib- HOCTblO. III) H3 BUUieonHCaHHOft nJia3MHAM yflaJIHK)T φρβΓΜβΗΤ NdeI X Pst I Η B npOnyCK JIHrnpyK)T φρ3ΓΜβΗΤ M2. nocjie ΤΡ3ΗθφθρΜΒΙ|ΗΜ B E.coli K 12 y M 103 h KyjibTMBnpoBaHHfl Ha cpene c 150 jtr aMrin-iļHJUiHHa/MJi, Bbi6npaioT τβ kjiohh, κοτορΗβ coflep*aT ruia3MHfly. OHa OTJIHiiaeTCH HaJIHWHeM φρβΓΜβΗΤβ Nde I x Pst I flJIHHOfl 246 tfn(M2) c npaBHJIbHO flOnOJIHHTeJIbHO ΠρΟΒβρβΗΗΟϋ IlOCJieflOBaTeJIbHOCTbK). IV) M3 nJiaSMHAU ynajfIHK)T φρβΓΜβΗΤΗ M2 Η M3 B BHfle NdeI X sac I $parMeHTa h JinrnpyioT b nojiyneHHyio nocjie pa3pe30B c noMOigb»
Nde I x sac I doJibiuyio «acTb 158-06 T. nocjie TpaHC®opMauHH b E.coli K 12 y M 103 η KyjibTHBnpoBaHHH Ha cpefle co 150/mr aM-nHHHJiJiHHa/Mji BHdHpaiOT Te kjiohh, KOTopne eoaepaaT njia3MHAy Nde 158-08 T. OHa OTJiH^aeTCH οτ pbf 158-06 T HajiH^HeM φρβΓΜβΗτβ Nde I X Sac I flJIHHOft 435 HyKJieOTH,T[OB. I) KoHCTpynpoBaHne njia3MHHH pbf!60. ββθβθηκθ ομητθτη^θο-κογο tro-npoMOTOpa.
OrmcaHHaH nocjieflOBaTejibHOCTb trp-npoMOTopa pacnpocTpaHH-eTCH ao Hba I Mecia pa3pe3a h yAJWHfleTCH y δ-KOHija c noMombio nocJieAOBaTejibHOCTH 5ΆΑΤΤΙΙΤΓΑΑΑΤ-3'. B pe3yjibTaTe θτογο KOHCTpy-HPyioT eco ri MeCTO pa3pe3a. OTflejibHHe hhth 021 h 021A AeHaTy-pHpyioT η jiHrHpyioT b njia3MHfly pBF 158-08 T, pa3pe3aHHyio eco ri X Xba I. nocjie τρΒΗΟφορΜΒΗΗΗ Β E.coli K 12 y M 103 H KyJIbTH-BnpoBaHHH Ha cpeae· co 150 flr aMnuiimuinHa/MJi Bu6npaioT Te kjiohh κοτορΗβ co^epaaT pBF 160. njia3MKfla pbf 160 OTJiHMaeTCH οτ Bcex BHUieonHCaHHHX npeAIIieCTBeHHHKOB ΤΘΜ, WTO DITaMMH 6aKTepnK, TaKHM Odpa30M Τρ3Η0φ0ΡΜΙφ0Β3ΗΗΗΘ E.coli, Ha A00aBJieHHe HHflOJiaKpHJIO-BOfi KHCJIOTH 3KCnpHMHpyi0T ΓφΟΤβΗΗ npeABapHTeJIbHOfi CTaAHH rscu-PA. g) OKcnpeccHOHHbift TecT:
i) iepMeHTaiļHH
Pa3JIWiHbie UJTaMMbl E.coli, ΤρβΗΟφΟΡΜΗρΟΒβΗΗΗ C nOMOUIbiO LV 10120 13. nJiaSMHflH pBF 160, HanpHMep E.coli GTR-I, E. coli K 12 y M 103, a TaK*e e. co.uk 12 ATCC31446,npn cooTBeTCTByiomnx 0AHHaK0Bbix ycjioBMHx (JepMeHTHpyK)T b cpefle, cocTOHmefi H3 38 mmoji cyJIbφaτa aMMOHHH, 56 mmoji φοοφΒΤΗΟΓΟ ^epa pH 7,0, I mmoji cyjib®aTa Mar-ηηη,Ι% αρομθβογο BKCTpaKTa, 1% rjuoK03H, coAepKameH 150 ΜΓ aw-nniļHJiJiHHa Ha jihtp, h HHAyunpyioT c πομοικβιο 62 μγ HHAOJiaKpHJioBoii khcjiuth/ji 3KcnpeccnK) npoTemia npeABapHTejibHOft οτθαηη rscu-PA. flJIfl CpaBH8HHH BbIUieHa3BaHHUe IDTaMMbl TpaHCφopMHpyK)T C nOMODIblO BbiineonncaHHOM njia3MHflbi, KOTopan coflepiHT reH ^ejioBe^ecKoK npo-ypoKHHa3u H3 6aHKa kJIHK, nojiytieHHoro H3 MPHK KJieTOK ίβτροίίτ 562 h MMerouiHM o6o3HaueHMe ρυκ 54 trp 207-1, h 3aTeM, npw oah-HaKOBbIX yCJIOBMHX, φβρΜΘΗΤ^ΙΟΤ H nOflBepraiOT HHAyKIļHH.
FlepeA MHflyKUHeK h Ka»flbif5 ^ac nocjie HHAyKiļHH, Bcero 6 wa- COB, ΟΟΟΤΒβΤΟΤΒβΗΗΟ ^eHTpnφyΓHpyK)T 1 MJI KJieTOUHOH CyCneHHHH C OnTMtieCKOR nJIOTHOCTbK) (0Π) I ΓφΗ 578 HM, H HCnOJIb3y!OT AJIfl TecTupoBaHHfi CTeneHH 3KcnpeccHH. II) OdpaTHan peaKUHH npoTeHHa npeflBapuTejibHofi CTaAHH ao rscu-PA, ero pacmenJieHHe AO rtcu-PA H Η3ΜβρβΗΗΘ aKTHBHOCTH. OTAeJieHHbie ^eHτpHφyΓHpoBaHHeM KJieTKH, KaK onncaHo Bbiine, COeAHHfliOT C JIH30UHM0M Η 33ΤΘΜ HCriOJIb3yK)T ΓΟΜΟΓβΗβΤ JIH3HpOBaHHHX KJieTOK ajih onpeAejieHHH βκτηβηοοτη, KaK onHcaHO Bbiine. CTeneHH 3KcnpeccHH, onpeAeJieHHHe TaKHM otfpaeoM, nocjie H3MepeHHfl aKTHBHOCTH rtcu-PA, 06pa30BaHHOfi H3 rscu-PA, nojiyue-Hbi H3 npoTeHHa npeABapHTejibHoK οτβαηη. OTCIOAa BHAHO, VĪTO UITaMMU E.COli, KOTOpue dHJIH ΤρβΗΟφΟΡΜΗ-poBaHbi c noMOīĶbio njia3MHAbi pBF 160, AaroT 10-15-KpaTHbiH βηχοα 3KCnpeCCHH, WeM nJia3MHA0fi pUK 54 trp 207-1 (10), Η3Ββ0ΤΗ0Η H3 jiHTepaTypbi τpaHcφopMHpyIoιneft TaKHe «e uitamm E.coli. KpoMe τογο 0Ka3aJI0Cb, ^TO BbIXOAH 3KCnpeCCHH BO Bcex DITaMMaX, B 3aBHCHM0C-TH OT HCn0JIb3yeM0il AJIH Τρ3ΗθφθρΜ3Ι4ΗΗ nJia3MHAH, Jie«aT npH6JIH3H-TeJIbHO ΠΡΗ ΟΑΗΗβΚΟΒΗΧ 3Η3Μ3ΗΗΗΧ, Τ.β., *ΙΤΟ ΙΙΙΤβΜΜΗ (ΗΘ33ΒΗ0ΗΜ0 OT OTAeJIbHbIX E.coli IDTaMMOB), ΤΡ3ΗθφθρΜΗρθΒ3ΗΗΗβ C ΠΟΜΟΙΙΙΒΚ) nJia-3μηαη pBF 160, BcerAa AaiOT bo μηογο pa3 6ojibuiyio CTeneHb 3Kcnpec CHH, yeM ΗΑΘΗΤΗηΗΜβ UITaMMbī, ΤΡ8ΗθφθρΜΗρθΒ3ΗΗΗβ H3BeCTH0ČĪ nJia3MH floft pUK 54 trp 207-1. • F1PHMEP 2.
a) KoHCTpynpoBaHHe 3KcnpeccH0HH0fi njia3MHAH pbf-161 αλη npoTeHHa npeABapMTeJIbHO^ CTaAHH rscu-PA c ΟΗΗΤβΤΗΜβΟΚΗΜ rscu-PA 14. ,-γθηομ ripu KOHTpoJie trp npoMOTopa. njia3MHfly p3R 322 pa3pe3a^H C nOMOmbIOEoo RI H Hind III f!ojiyyeHHHii φρβΓΜθΗΤ fljiKHoft 31 HyKJieoTHfl OTfleJiHJin c πομοπιμ) nofl-roTOBHTejibHoro 3Ji6KTpo$ope3a Ha arapo3HOM rene. OcTaBmyK)CH wacTb pBF 322 aJUOMpOBaJIH C ΠΟΜΟΙξΕΙΟ 3JieKTp03JIK)Hp0BaHHH H3 ΓβΛΗ H ΟΗΗ-majin c noMombK) HE 52. njia3MHfly pbf 160 (npHMep II) TaK«e pa3pe3aroT c noMombio ECO RI H Hind III Η φρβΓΜΘΗΤ Eco RI X Hind III flJIHHOfi 1684 HyK-JieOTHfla, ΚΟΤΟρυΚ COflepKHT ΟΗΗΤΒΤΗΗβΟΚΗίί scu-PA -ΓΘΗ CO BC8MM eflHHHpaMH peryjmpoBaHHfl (trp-προΜοτορ), οτ,ΐίβΛΗιοτ c noMombfo 3JieK-τροφορβ3β Ha arapo3HOM rene, sjimpym KaK onncaHo sunie h ohh-maioT. noJiy^eHHbie TaKHM o0pa30M φρβΓΜθΗΤΗ JinrapyK)T oChuhhm cno-COČOM C nOMOlUbJO T4-JIHra3U H 38ΤΘΜ TpaHC®0pMHpyiOT B E.coli K 12 M 103. flocne KyjibTHBnpoBaHHfl Ha cpene co 150 jtr aMnwinnnHHa/Mn BbīdnpaiOT Te κλοηη, κοτορηθ co^epstaT φρβΓΜβΗτ eco ri x gīnd m nnHHoft 1684 HyKJieoTH,qa h npoflypnpyioT προτβΗΗ rscu-PA npeflBapn-TejIbHOH CTaflHH nOCJie flOČaBneHHfl HHflOnaKpHnOBOfl KHCJIOTU. 8th kjiohu conepaiaT nna3MH,ņy pBF 161. b) 3KCnpeCCH0HHblft ΜΘΤΟΛ-ΤΘΟΤ. E.coli GRT-I, E.coliK 12 y M 103 H E.coli K 12 ATCC 31 446 ΤΡ8ΗθφθρΜ^Ε0Τ G ΠΟΜΟΙ«ΒϊΟ pBF 161 Η 38ΤβΜ φβρΜβΗΤ^ΙΟΤ ΚβΚ onncaHo b npHMepe Ig h HcnbīTUBaioT pe3yjibTaT BKcnpeccnH. Βηχο£η rscu-PA προτθΗΗβ npeflBapHTenbHofi CTaflHH onpenejiHioT Kan rscu-PA aKTHBHOCTb ^epe3 1-6 HaCOB nOCJie HHHyKlJHH H OHH CpaBHHMH co 3HayeHHHMH ΒΜΧΟΛΟΒ njia3MHflbi pBF 160 nojiytieHHMX πρΗΜθΗθΗΗβΜ nna-3MHflbI pBF 160 flJIH ΤΡ3ΗθφθΡΜ814ΗΗ. nojiyyeHHbiH no aHanomu c npuMepoM īgi qeHTpn®yrnpoBaHneM KJieTO^HbiH ocauoK μοκθτ 6biTb TaKffie nonyweH nyīeM κηπηηθημη b 0,25 moji tphc HCI-(5y<ī>8pe, pH 8,0 c 4% HaTpnMfloneqnncynb®aTa, 1% MepKanT03TaH0Jia m 20¾ rnmļepMHa. PacTBopeHHbie τθκημ o6pa-30M ΠΡΟΤΘΗΗΗ OTUeJIfllOT C nOMOUļblO SDS-PAGE H fleJiaiOT BHflHMblMH C noMombK) OKpamuBaHHfl KyMaccdnK> (12). OKpaineHHHe reņu oneHHBaioT HeHCHMeTptmecKM κ HHTerpnpyioT nHTHa cpenH īihkob, KonimecTBo 0dpa30BaBll!er0CH nOCJie HHHyKUHH HHflOnaKpunOBOft KHCnOTOfi rscu-PA npoTeHHa npeflBapuTenbHoft CTaflHH, onpenennioT c noMonibio cydcTpaK-IļHH ΠΗΤβΗ, ΗΗΛΘΗΤΜφΗΙΙΙφΟΒβΗΗΗΧ B KaHeCTBe ΠρΟΤΘΗΗβ npeflBapHTeJIb-hoh CTaflHH nojioc nepefl HH,ņyKiJ(neii, ot nojioc, nojiyyeHHbix nocne MHflyKLļHH. LV 10120 15. B BHnieoriHcaHHOM npHMepe KOJimiecTBO rscu-PA npoTeHHa npe^Bapn-TejibHOH cTaflHH nocJie hh^klīhm cocTaBJineT 17,9 Bec.% ČaKTepn-ajībHoro očmero npoTeHHa. Hpyrne npHMepu yKa3aHbi b Tataije I.
TABJIMJA I
KojiH^ecTBO rscu-PA npoTeHHa npeflBapHTejibHoM CTaflMM ot o6mero KOJitmecTBa npoTeHHa ( b npoqeHTax).
TpaHC$opMHpoBaHHbiii [IlTaMM E. COli pBF 161 pUK 54 trp 207 K 12 ATCC 31446 14 1,5 K12 y M 103 17,9 1,9 GRT-1 17,8 1,7 ΠΡΜΜΕΡ 3.
KoHCTpyHDQBaHMe βκοπρθοομοηηοη njia3MMjibi jjih npoTerma npeflBaPHTeJIbHOH CTaflHM rscu-PA C ΟΜΗΤΘΤΜ^ΘΟΚΗΜ scu-ρα-γ.θηομ ripu KOHTppjie trp-npoMOTOpa b pbr 322 c flejiemieft β γθηρθ3ηο ΤΘΗΤΗΟΟΤΗ K TeTPaUHKJIMHy. a) KoHCTpynpoBaHne njia3MHAbi pbr 322 dei.
njia3MHfly pBR 322 pa3pe3aioT c πομοιιιβιο arapo3ereJib8JieKTpo-φθρΘ33, OCTaTOUHOe KOJIHUeCTBO pBR 322 H3 reJIH 3JIK)HpyK)T C nOMODlblO 8JieKTpo3JiK)HpoBaHHH, o^HiiļaKT wepe3 HE 52 Tynue KOHUbi pBR 322 Eco-RV X Nru I-OCTaTOWHOK qaCTH, H Ο&ΜΗΗΜ 0dpa30M JIHrHpyiOT c nOMOlIļbK) T4-JIHra3bI. nocJie ΤΡ3ΗθφθρΜ3Ι1ΜΗ B E.coli κ 12 y M 103 h KyjibTMBHpoBaHHH Ha cpefle co 150 μγ aMnnmuuiHHa/MJi BuOHpaiOT
Te KJIOHH, H3 ΚΟΤΟΡΗΧ 3ΛΗΚΒ0ΤΗ3Η UaCTb ΠΟΟΛβ ΠβρβΗβΟΘΗΗΗ Ha cpeny c 25 μγ TeTpauHKJiHHa /mji Ha Hei* ηθ BbipacTaeT, T.e., He oOjiaflaeT TeTpauHKJiMHOBoft pe3ncTeHTHOCTbio. Kjiohh conepsaT njias-MHfly pbr 322 del, KOTopaa OTJiHuaeTCH ot pbr 322 τβΜ, uto OHa Ha 787 HyKJieoTHflOB MeHbiiie, qeM h ηθ MoseT 6biTb pa3pe3aHa 6ojiee C nOMOUļbfO ECO RV H Nru I. b) KoHCTpynpoBaHne njia3MHflw pbf 162. pBF 322 del pa3pe3atoT c noMombio eco rv h Hind III. nojiy-tieHHuii trkmm odpasoM φρ3ΓΜβΗΤ λληηοΚ 31 HyKJieoTHH, οτλθληιοτ c nOMOUlbfO npenapaTHBHOf! 3Γ8ρθ3βΓΘΛΒ8.ΠΘΚΤρθφθρθ33, OCTaTOWHyiO WaCTb pBR 322 del 8JH0HpyK)T C nOMOmblO 8JieKTp08JIK)Hp0BaHHfl H3 ΓΘΛΗ H o^HmaiOT HE 52. 16. , l
TaKHM'otfpasoM Η3 pbf 160 nojiytiaioT Φρθγμθητ eco ri x Hind III flJIHHOČi 1684 HyKJieOTHflOB, KOTOpblft COflepMT CHHT8THlieC-KHH scu-PA -ΓΘΗ CO ΒΟβΜΗ eflHHHliaMH peryJIHpOBaHHH (trp -npOMOTOp)
Oda $parMeHTa odbmHbiM odpa30M jinrnpyjoT T4-JiHra3oft h 3aTeM TpaHc$opMHpyiOT b E.coli K 12 y M 103 KJieTKH. HocJie KyjiBTHBH-poBaHHH Ha cpefle co 150 μγ aMnnitiuiJiHHa/ΜΛ BbīdHpaioT kjiohh, ko-Topbie coflepffiaT OparMeHT eco ri x Hind III αληηοη 1684 dn h npoflyunpyioT nocJie nodaBJieHHH 62 μγ HHflOJiaKpmioBOfi khcjioth/mji rscu-ΡΑ-προτθΗΗ npoMe»yTotļHoft CTaflHH. kjiohu conepsaT iuia3-MHfly pBF .162. c) 3KcnpeccH0HHbiii τβοτ. Ē. coli GRT-I TpaHC(£opMHpyiOT C nOMOIHBK) pBF 162, H 3aTeM $epMeHTHpyK)T, κβκ orracaHo b npHMepe I η μοπητηββιοτ pe3yjibTaT 3K-cnpeccHH. Βηχοαη rscu-PA -npoTeHHa npeflBapHTeJibHOfi CTaflHH on-peneJIfliOT KaK rscu-PA-aKTHBHOCTb Μβρβ3 6 tiaCOB nocJie HHflyKUMH, KOTopan cocTaBJiHeT 1300 pu /mji ΚΛβτο^ΐΗοίί cycneHEļnn c onTHtiecKoft nJIOTHOCTbEO I, H CpaBHHM3 CO 3HaWeHHHMH BbIXOflOB nocJie τρβΗΟφΟΡ-MaUHH E. coli GRT -I C nOMOHlbK) nJia3MHflb! pBF 160, ΠΡΜΜΕΡ 4.
KoHCTpywpoBaHne SKcnpeccHOHHofi njia3MHflH pbf 171 ajih npoTeHHa npeflBapHTejibHofi CTaflHH rscu-PA c CHHTeTmiecKKM scu-pa--ΓΘΗΟΜ npH KOHTpOJie tac -npOMOTOpa. n^a3MHfly pBF 161 pa3pe3ajoT c noMombro Eco ri x Xba i. no^y^eHHbiii φρ3ΓΜ8Ητ αληηοΚ 74 HyKJieoTHfla οταθαηϊοτ c noMOiiļbio npenapaTHBHOrO 3ΓΒρθ36ΓΘ.ΠΒ3.Π8ΚΤρθφθρβ33, OCTaTOWHyiO tļaCTb ΠΛβ3-MHflbl 3JIK)HpyK)T C nOMOIIļbK) 3JI(OHpOBaHHfl Η 3βΤΘΜ O^HUiaiOT C ΠΟΜΟΙΰΒΚ) ΛΕ 52. H3 nJia3MHflbI ptac SDT ( DSM 5018) BblfleJIHlOT φρ3ΓΜΘΗΤ Eco RI ,x Xba I , KOTOpblft COflepffiHT tac-πρΟΜΟΤΟρ. HjIH 3Τ0Γ0 pa3pe3aioT ptac sdt c πομοιιιβιο eco ri x xba I h οταθληιοτ $par-MeHT c noMombio npenapaTHBHoro nojiHaKpHJiaMMflrejieBoro θΛβκτροφο-pe3a. ΦρβΓΜβΗτ 3JuonpyioT c πομοικμ) HarpeBa flo 65°C b aMMOHHfiaije-TaT/SDS -^φβρβ, pH 8,0 h MexaHHtiecKH H3Mejib*ieHHoro nojinaKpmi-aMHfla, H OUHUtaiOT ΜΗΟΓΟΚρβΤΗΟΗ 3KCTpaKIJHeft φβΗΟΛΟΜ, KOTOpblft Ha-cameH I moji τρκο^φβροΜ, pH 8,0.
Oda noJiyyeHHbix TaKHM odpaeoM φρβΓΜβΗτβ odu^HUM odpa30M jinrnpyiOT T4-jinra3oii h 3aīeM TpaHC$opMHpyioT β E. coli K 12 y M 103. flocjie KyjibTHBnpoBaHHfl Ha cpefle co 150 βΜπιιΐ1ΜΛΛΗΗβ/ΜΛ 17. LV 10120
BblČHpaiOT KJIOHbl, ΚΟΤΟΡΗΘ nOCJie ΛΟββΒΛΘΗΗΗ ΜΠΤΓ npOflyqHpyK)T rscu-PA προτθΜΗ npeflBapHTejiBHOii CTaflHM. 0TM kjiohh coflepaaT ruia3MHfly pBF 171. 6) 0KcnpeccnoHHbifi TecT. Ē. coli K 12 y M 103 TpaHC®opMHpyiūT c noMombio pbf 171, h 38τβΜ φβρΜβΗΤΜργιοτ, κθκ onncaHO b npMMepe Ig ) h HCCJie,qyīOT pe3yjibTaT 3Kcnpeccnn. Mhotuhio ocyinecTBJiHJOT c noMouļbio ποΛκβκριω-aMUJirejieeBoro 3Λβκτροφορθ3Β ( KOHe^Han KOHiieHTpauHH 0,5 mmoji). Βηχοαμ rscu-PA -npoTemia npeflBapHTejibHoii ctsahh, onpe^e-JIHKJT B BMJļe rtcu-PA aKTHBHOCTH Ηθρθ3 1-6 «acOB nOCJie HHUyKIJHH. ΟΠΗ CpaBHHMbl CO 3HaUeHMHMH BbIXOflOB, nOJiygeHHbIMH ΓφΗΜβΗβΗΗβΜ nJia3MHflbI pBF 160 B OflHHaKOBbIX ΜΤ3ΜΜ3Χ E. COli. ΠΡΗΜΕΡ 5. а) KoHCTpynpoBaHHe 3KcnpeccH0HH0ft njia3MMflu pbf 172 kjih rscu-PA -npOTenHa npeflBapHTejibHof! CTaflHH c CHHTeTimecKHM scu-γθηομ npH KOHTpojie tac-npoMOTopa b pBR 322 c fl.ejieijMeft β γθηθ pe3cnTeHTH0CTH κ TeTpaunKJiHHy.
IlJia3MHfly pBR 322 del (cm. npHMep 3a) pa3pe3aioT c πομο-UļblO ECO Rī x Hind III . riOJiyHeHHblfi φρβΓΜΘΗΤ flJIHHOft 31 HyKJieOTHfl OTflejiHiOT c noMombK) npenapaTMBHoro arapo3orejieBoro θΛβκτροφορβ-3a, ocTaToyHyro gacTb pBR 322 del 9jnoHpyioT c noMouibio 9JieKTpo-3JIK)MpOBaHHH H3 ΓΘΛΗ H 3aTeM OHHUiaiOT flE 52.
TaKHM »e o(5pa30M nojiygaioT H3 pbf 171 φpaΓMβHT Eco rix Hind III, KOTOpblfi COflepMHT CHHTCTHUeCKHK scu-PA -ΓβΗ C.O BC6MH eflHHHIiaMM peryJIHpHOCTH ( tac-npOMOTOp). 06a nojiyueHHbix TaKHM o6pa30M φρ3ΓΜθΗΤ3 JiHrHpyiOT ο6ηηηημ o6pa30M T4 Jinra3oft h saTeM τpaHCφppMHpyκ)τ b E.coli K 12 y M 103 kji©tkh . Oocjie KyjibTHBHpoBaHHH Ha cpejie co 150 μγ aMnHUHJi-jiMHa/MJi BudHpaioT KJioHbi, ko. opbie npoflyqHpyFOT b npHcyTCTBHH 0,5 mmoji ΜΠΤΓ rscu-PA -προτβΗΗ npeflBapHTeJibHofi CTaflHH. Θτη kjiohh coflepmaT njia3MHfly pbf 172. б) OKcnpeccHOHHHfi τβοτ. E. coli K 12 y M 103 τpaHcφopMHpyίoτ c noMombio pbf 172 h 33τβΜ φepMeHTMpyκ)τ KaK onHcaHo b npMMepe 16 ) h HCCJieflyioT pe-3yjIbTaT 3KCnpeCCHH. HhJ^KIIHK) OCymeCTBJIHK)T C nOMOUIbK) Ι4ΠΤΓ (ko-HetļHan KOHLieHTpaijHfl 0.5 mmoji). Βηχοαη rscu -npoTeHHa npenBapn-TeJIbHOfl CTaflHH OnpefleJIHlOT KaK rtcu-PA -aKTHBHOCTb uepe3 1-4 18. tiacoB nocjie MHflyKLiHH h OHa cocTaBJineT πρκ<5λη3ητθλβηο 1100 /mji KJieTCmHOfl CycneH3HH ΟΠΤΗ«ΘΟΚθβ IUIOTHOCTH I H CpaBHHMH CO 3Ha-MeHHBMH ΒΗΧΟΛΟΒ, ΠΟΛ^βΗΗΗΧ ΠΡΗΜΘΗΘΗΗΘΜ nJia3MHflbl pBF 160 C ΤβΜ Κθ ΙΙΙΤβΜΜΟΜ E.coli. ΠΡΜΜΕΡ 6 Μ3μθηθηηθ paccTOHHHH MejRAy Hl.fl.-nocjieflOBaTejibHOCTbio h CTapTOBHM KOflOHOM B 3KCnpeCCH0HH0fi nJia3MHfle flJIfl rscu-PA -ΠΡΟ-TeHHa npeflBapHTejibHO^ CTannn. CTapTOBfeIH KOflOH, ATG , OriHCaHHblfi BO Bcex KOHCTpyKUHHX npuMepoB 1-5, ABJineTCH cocTaBHofi wacTtio Nde-I-MecTa pa3pe3a -CATAT - Nde -I, pa3pe3aeT 3a πθρβημ A reKcaHyKJieoTMHHyK> nocjie-AOBaTejibHOCTb h jņaeT 5-kohph, κοτορκβ nepeKpHBaioT flBa οοηοββηηη. SanoJiHHioT 3-KOHiļbi, T.e., KOHCTpynpyiOT Tynbie kohiih, h nocjie 3to-ro cHOBa jinrnpyioT τβκ, φγο cooTBeTCTByioinaH nocjieflOBaTejibHOCTb yfljiHHHeTCH Ha οοηοβημθ napu. OflHOBpeMeHHO yflajiHioT Nde Ι-μθοτο, PaccTOHHne ot M.H.-nocJieflOBaTejibHocTH flo CTapTOBoro KOflOHa yn-jmHHeTCH ot 8 no 10 οοηοβηηχ nap. B najībHefiiDeM, 3KcnepnMeHTajibHoe npoBefleHne ποηοηηθτοη b npHMepe: а) KoHCTpyKLjHfl nJia3MHflbi pbf 163. flJia3MKfly pbf 161 pa3pe3aioT c πομοιιιβκ) Nde i, 3aTeM bh-CTynaiomHe kohhn 3anojiHHfOT Φρθγμθητομ KjieHOBa nojiHMepa3bi I IIHK (2). nocjie 3τογο JinrnpyiOT ο6η«ηημ o6pa30M T4-jinra3ofi h 33ΤΘΜ τρβΗΟφορΜΗριηοτ b.E. coli K 12 y M 103. nocjie KyjibTHBHpoBaHHH Ha aMnuuHJiJiHHOBOH cpene BbidMpaioT kjiohh, KOTopbie coflepffiaT ruia3-MHfly pBF 163.OHa OTJītmaeTCH ot pbf 161 0TcyTCTBH6M MecTa Nde H flOnOJIHHTeJIbHUM 00Η0Β3ΗΜβΜ -ΤΑ- B OČJiaCTH ΠΡΘΚΗβΓΟ Nde-Ī -I-MecTa. б) BKCnpeCCMTHHblR τβοτ. E. coli GRT-I TpaHC$OPMHpyiOT C nOMOlUbK) nJia3MHflH pBF 163, μ 33τθμ φθρΜβΗτκρνΒτ, Kax onncaHo b ripuMepe I g) η κοπϋΤΗΒβιοτ pe3yjibTaT 3KcnpeccnH. Βμχολη rscu-PA -npoTeHHa npenBapuTejibHofi CTaflHH, onpefleJiflioT nocjie očpaTHofi peaKunii h 3κτηβηροβ3ηηη b BHfte rtcu-PA -aKTHBHOCTH Ha KJieTOUHOii cycneHLiHH c onTtmecKoii πλοτηοοτβκ) I, yepe3 1-7 qacoB nocjie hh^kphh 62 mji HHfl0JiaKpn-jioboh khcjiotom/ji. Ohh cpaBHHMH co 3HaneHHHMH BbixoflOB, nojiyueH-HblMH ΠΡΜΜΘΗΘΗΗΘΜ rUia3MHflbI pBF 160 B TOM »Θ ΙΙΙΤΒΜΜΘ E.COli. , 19. LV 10120
ΦΟΡΜΥΛΑ H30BPETEHHA 1) Cnocod nojiyweHHH ηοβηχ iuiasMHfl λλη πρΗΜθΗβΗΗϋ npH no-JiyweHHH njia3MHH0reHH0r0 aKTHBaTOpa, OTJIHiiafOHHftCH τθμ, uto njia3MMiiy pBR 322, H3 κοτοροΑ yflajieHa nic/bom o&iacTb M/MJIM ΠΟ MeHbDiefi Μβρβ MaCTb ΓΘΗΘ ΡΘ3Η0ΤΘΗΤΗ00ΤΗ K TeTpaiJHKJIMHy, Me»fly MecTaMH paspeea eco ri h Hind m "MyjibTHKJiOHHpyioinero" caitoa BBOflflT c HyKJieoTHflHoii nocjiefloBaTejibHocTbio, KOTopan Mew MecTaMH pa3pe3a xba i h Nde i coflepiHT nocjieflOBaTe^bHocTb tae-lļajībrapHo h Ha paccTOHHHM 6-12, npe,ņno™TejibHO 8-10 HyK-JieOTHflOB, - CTapTOBH^ KOflOH ATG, H c ero nOMOIUblO BCTpaHBaiOT H3-BeCTHblM 06pa30M B OflHH Μ1Λ flBB TpaHCKpnniļHOHHbIX TepMHHaTOpa, CMHT6TnuecKyK) tiacTHWK) ποολθ,ι;οβ8τθ.πβηοοτβ scu-pa -cīpyKTypHO-ro reHa, npe^notiTHTejibHo Ha^HHafomjnocH ot 3'-K0Hua CTpyKTypHoro reHa, a τθκ«θ peryjinpyeMbift προΜοτορ, h TaKHM 00pa30M nojiytiatoT nJia3MHflu, KOTopbie ofijiajiaioT cjie,qyK)innMn OTJiHtiHTejibHbiMH πρμ3Η3Κ3μη: а) OnepoH πμθμηαν coflep*HT peryjmpyeMbifi προΜΟτορ, b Ka-uecTBe Μβοτβ οοθαμηθημη ph(5ocom - nocjieflOBaTejibHocTb UlHHe-flajib-rapHo, cīapTOBbin koaoh, cnHTeTiwecnft CTpyKTypHHH reH jijih ozi-ηοημτθβογο aKTHBaTOpa yponJia3MHHoreHa M scu-pa ", coflepaamero 411 aMHHOKHCJIOTHUX OCT3TKOB ,H, BHH3 OT CTpyKTypHOrO reHa, OflHH -flBa TepMHHaTOpa; б) flJia3MHflbl npHrOflHbl flJlfl 3KCnpeCCHH rscu-PA -ΠρΟΤΘΗΗΒ npeflBapHTejibHofi CTa,qnn co οτθπθηβιο 3KcnpeccMn no μθηβπιθΑ Mepe 10 Bec. % o(5pa30BaBDierocfl odinero npoTenHa b 3HTepo6aKTepwnx, npe,ņnOUTHTeJIbHO B ΙΙΙΤΒΜΜΒΧ Escherichia coli. 2) Cnocod no n.I, OTJiimaiomHfiCH τβΜ, ^το b KauecTBe pery-jinpyeMoro npoMOTopa BCTpanBaioT trp hjih tac -προΜοτορ c noMoinbio MyjibTHKJioHHpyiomero caiiTa. 3) . Cnocod no π.π. I n 2, oTJiimaiotnHftCH τθμ, uto b KatiecTBe pery;inpyeMoro npoMOTopa BCTpanBatoT cHHTeTnuecKHft trp -προΜοτορ b HyKJieoTHiiHoK nocjieflOBaTeJibHocTH. 4) . Cnocotf no π.π. 1 m 2, oTJiimaioinHftcH τθμ, μτο b KawecT-Be peryjinpyeMoro npoMOTopa BCTpanBaioT tac -προΜοτορ H3 πμθμμ-ΛΜ ptac SDT ( DSM 5018).
5 ). Cnoco6 no π. 1, oTjmaioinHftcfl τθμ, χιτο b κθχιθοτβθ CJieflyioinnx jņpyr 3a flpyroM TpaHCKpnniļH0HHbix τθρμηηθτοροβ βοτρθη-ΒβίΟΤ trp A-TepMHHaTOP H/HJIH tet A/orf L -ΤβρΜΗΗβΤΟρ H3 T n 20. LV 10120 10 B OnepOH ΗΟΒΗΧ nJia3MH,E(. 6). CnocoG no n.I, OTJinuaiomniicfl τθμ, χιτο c noMOiubto mjtjib-THKJioHnpyiomero cafiTa b uacTHtiHofi CTaflHH BCTpanBaeTCH οτργκτγρ-ηηη γθη c HyKJieoTHflHoii nocjieflOBaTejibHocTbH). ?). Cnoco6 ΠΟΛΥΣΗΜΗ ηοβηχ njia3MHfl no π. I, oTJimiaiomHi?- CH ΤΘΜ, tlTO Eco RI x Hind III $Ρ8ΓΜΘΗΤ H3 n0JiyiieHH0ft B C00T- βθτοτβηη c πγΗκτβΜΗ 1-6 njia3MHnbi, Hcnojib3yioT b Ka^ecTBe 3kc-npeccnoHHofi KacceTbi b npyrofi, b flpyrow, 3HTepo6aKTepHajībHHfi, npenno^THTeJibHO, b cnoco6Hyio pa3MH0*aTbCH θβτοηομηο n;ia3MHfly E. coli. 8) Cnocod nojiyweHHH ηοβηχ njia3Mn.ii no n.I, OTJiHuaiomHficfl ΤΘΜ, 4T0 B nOJiyweHHOft B COOTBeTCTBHH C ΠΥΗΚΤΒΜΜ 1-7 B nJia3MHfle yHJiHHHioT paccTOHHHe Me»fly nocJienoBaTejibHocTbio lŪHHe-HaJībrapHo H CTapTOBHM KOflOHOM ΠγΤΘΜ pa3pe3a C nOMOUIbK) Nde I, 3anOJIHeHHH no;iyqeHHbix μθοτ pa3pe3a h nocjieflyiomero jiHrHpoBaHHH noJiyweHHbix Tynux KOHUtOB. 9) ΠρπΜθΗβΗΗβ nojiyweHHofi no πυηκτβμ 1-8 njia3MHflbi npH no-jiyyeHHH njia3MHHoreHHoro aKTMBaTOpa, OTJiHwaiomHiicH τθμ, wto θτοΑ nJia3MHfloft TpaHC$opMHpyioT BHTepofiaKTepnaJībHHii ηιτβΜΜ, npennouTM-TeJIbHO UJT3MM E. coli Κ3ΒΘ0ΤΗΗΜ θ6ρβ30Μ, HHflyiiHpyiOT ΘΚΟΠρβΟΟΗΚ) scu-PA -οτργκτγρΗΟΓΟ reHa, o6pa30BaBUiHficH προτΘΗΗ-rscu-PA, npoMe?«yTowHoK cTaflHH, oTflejinioT ot cpeflu h JiH3HpyioT ČaKTepHajībHue KJieTKH, προτβΗΗ npeflBapHTejibHofi οτβληη CTaČHJiH3HpyiOT h 3aTeM nonBepraioT odpaTHOfi peaKUHH no rscu-PA b pe3yjibTaTe B03nefiCTBHH penoKc-CHCTeMbi. 10) ΠρΗΜΘΗΘΗΗΗ nOJiyweHHOft no ΠΥΗΚΤΘΜ 1-8 nJia3MHflbI npn nojiyqeHHH njia3MHHoreHHoro aKTHBaTopa b οοοτβθτοτβηη c πυηκτομ 9, OTJiHtiaroineecfl τθμ, wto θτο8 njia3MHnoft τρβηοΦορμηρυιοτ uiTaMM BHna E.coii , npenno^THTejibHo, uiTaMM K12 E.coli , h 3aTeM ocymecTBJiHK)T cnoco6 no n. 9. LV 10120 ΡΕΦΕΡΑΤ ΜθοΰρβτβΗΗβ KacaeTca πολώθηκα ηοβηχ πλθθμηα c οιίητθτμ-tjecKofi nocaeflOBaTeabHocTbio ,ΠΗΚ, κοτορΗθ πρμγοληη 9iccnpnMnpoBaTb προτβΗΗ npeflBapMTejibHofi CTafinu rscu-PA (τ.β. HerjiHKoaminpoBaH-Hyro tiacTb προτβπΗθ oflHoueriHofi npoypoKHHa3bi) b βητθρο63κτθρμηχ , B «aCTHOCTH E.coli B ΚΟΛΗΜβΟΤΒβ, KOTOpbie flaiOT BbIXOfl, 3HaWHTeJlb- ho npeBbimaromutf βηχολη, flocTuraeMbie npn H3BecTH0M πρΜΜβΗβΗΜΊ naa3MMfl. noaytiaromnecH b οοοτβθτοτβμμ c Μ3θ6ρβτβΗΗβΜ njia3MHflbi,xapax-Tepn3yioTCH τβΜ, uto hx onepoH odJiaflaeT peryjinpyeMbiM, b οοοτβθτ-CTBywm6M cjiyqae θΜΗΤβτκ«βοκΗΜ προΜοτοροΜ, UlMHe-flaabrapHo-nocjie-AOBaTeJIbHOCTblO, CTapTOBbIM KOflOHOM, ΟΜΗΤΘΤΗΙίΘΟΚΗΜ CTpyKT^pHblM γθηομ h, pacnojioffieHHbiM BHH3 ot CTpyKTypHoro reHa, ΠΟ MeHblIiefi Mepe, oflHHM TepMHHaTopoM. nojiyueHHe ηοβμχ njia3MMfl, a TaK»e ΟΜΗΤβΤΗΜβΟΚΜΧ Π00·Πββ0Β3ΤΘ.ΠΒΗ00ΤβΚ βΗΚ, OCymeCTBJIAK)T UCXOflfI H3 ΜΜβϊΟΐρΧΟΗ B npOflaffie nJia3MHfl. ΘΚΟΠρΗΜΙφΟΒβΗΗΗΛ ΠΡΗ ΗΧ ΠΡΜΜΘΗΘΗΜΗ b BucoKOfi οτβπβΗΜ προτβΗΗ npeflBapHTejibHoft CTannn κββθοτηημ 06-pasoM noflBepraraT odpaTHoii peaKUHH ao TepaneBTH^ecKH ncnojib3ye-Moro b KaqecTBe njia3MoreHHoro aKTHBaTopa rscu-PA , κοτορηίί 3a-ΤΘΜ, npM JKSJiaHHM, Τ3Κ!Κβ ΠρΗ OCymeCTBJIHeMOM Η3ΒβΟΤΗΗΜ odpa30M pacmenJieHMH, ΜΟΜβΤ dbITb HCn0JIb30BaH flJIH nOJiy^eHHA B T6XHHt|6C-kom MacuiTade flByxuennoro HerjMK03HJīnpoBaHHoro ypoKHHa3onpoTe-HHa (rtCU-PA ) .

Claims (9)

  1. LV10120 Izgudrojuma formula Jaunu plazmīdu iegūšanas paņēmiens·un to izmantošana plazminogēna aktivatora iegūšanā 1. Jaunu plazmīdu iegūšanas paņēmiens plazminogenā aktivatora iegūšanai, atšķiras ar to, ka plazmīdu pBR 322, no.kuras aizvākts nic/bom apgabals un/vai vismaz dala rezistences gēna pret tetraciklīnu, starp Eco RI un Hind III griezuma vietām "multiklonējošā" saitā, ·ievada ar norādīto nukleotīdu secību, kura starp Xba I un NdeI griezuma vietām satur Šinē-Daļgarno virkni un 6-12, vislabāk 8-10 nukleotīdu attālumā - starta kodonu ATG, un ar tā palīdzību ar zi nāmu paņēmienu iebūvē vienā vai divos transkripcijas terminatoros sintētisko daļējo scu-PA-struktūrgēna virkni., kas vislabāk sākas no struktūrgēna 3'-gala, kā arī regulējamo promotoru un tādā veidā iegūst plazmīdas, kurām ir sekojošas atšķirīgas pazīmes: a) plazmīdas operons satur regulējamu promotoru, ribosomu savienojuma vietā - Šinē-Daļgarno virkni, starta kodonu, vienpa-vediena uro-plazminogena "scu-PA" aktivatora sintētisko struk-tūrgēnu, kurš satur 411 aminoskābju atlikumus un lejup no struktūrgēna vienu-divus terminatorus? b) plazmīdas derīgas iepriekšējās stadijas rscu-PA proteīna ekspresijai ar ekspresijas pakāpi vismaz 10 svara % no ente-robaktērijās, vislabāk Escherichia coli celmā, veidojamā kopējā proteīna.
  2. 2. Paņēmiens saskaņā ar l.p., atšķiras ar to, ka kā regulējamo promotoru ar multiklonējošā saita palīdzību iebūvē trp- vai Tac-promotoru.
  3. 3. Paņēmiens saskaņā ar l.p. vai 2.p., atšķiras ar to, ka kā regulējamo promotoru iebūvē sintētisko trp-pro-motoru nukleotīdu virknē.
  4. 4. Paņēmiens saskaņā ar l.p. vai 2.p., atšķiras ar to, ka kā regulējamo promotoru iebūvē tac-promotoru no 2 pt-ac SDT (DSM 5018) plazmīdas.
  5. 5. Paņēmiens saskaņā ar l.p., atšķiras ar to, ka kā vienu otram sekojošos transkripcijas terminatorus jauno plazmīdu operonā iebūvē trp A-terminatoru un/vai tet A/orf L-terminatoru no Tn 10. Paņēmiens saskaņā ar l.p., atšķiras ar to, ka daļējā stadijā ar multiklonējošā saita palīdzību iebūvē struktūrgēnu ar nukleotīdu virkni.
  6. 7. Jaunu plazmīdu iegūšanas paņēmiens saskaņā ar l,p,, atšķiras ar to, ka plazmīdas fragmentu, kura iegūta saskaņā ar l.-6.p.p., Eco RI x Hind III izmanto kā ekspresijas kaseti citā, enterobaktēriju, vislabāk autonomi vairoties spējīgā E.coli plazmīdā.
  7. 8. Jaunu plazmīdu iegūšanas paņēmiens saskaņā ar l.p., atšķiras ar to, ka plazmīdā, kura iegūta saskaņā ar l.-7.p.p., pagarina attālumu starp Šinē-Daļgarno virkni un starta kodonu, sašķeļot ar Nde I, griezuma vietas·aizpildot un sekojoši trulos galus ligējot.
  8. 9. Saskaņā ar l.-8.p. iegūtās plazmīdas izmantošana plazminogenā aktīvatora iegūšanā, atšķiras ar to, ka ar šo plazmīdu transformē enterobaktēriju celmu, vislabāk E.coli celmu ar zināmu paņēmienu, inducē scu-PA struktūrgēna ekspresiju, atdala, starpstādijā izveidojošos rscu-PA proteīnu no vides un iepriekšējās stadijas lizētās baktēriju šūnas, proteīnu stabilizē un pēc tara redoks-sistēmas iedarbības rezultātā pakļauj atgriezeniskai reakcijai līdz rscu-PA.
  9. 10. Saskaņā ar l.-8.p. iegūtās plazmīdas izmantošana plazminogenā aktivatora iegūšanā saskaņā ar 9.p., atšķiras ar to, ka ar šo plazmīdu transformē E.coli celmu, vislabāk E.coli K 12 celmu, un pēc tam veic paņēmienu saskaņā ar 9.p.
LVP-92-204A 1989-07-19 1992-11-13 Method of producing of new plasmides and using thereof in producing of the plasminogen activator LV10120B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3923866 1989-07-19

Publications (2)

Publication Number Publication Date
LV10120A LV10120A (lv) 1994-05-10
LV10120B true LV10120B (en) 1994-10-20

Family

ID=6385369

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-204A LV10120B (en) 1989-07-19 1992-11-13 Method of producing of new plasmides and using thereof in producing of the plasminogen activator

Country Status (30)

Country Link
US (1) US5637503A (lv)
EP (1) EP0408945B1 (lv)
JP (1) JP3236284B2 (lv)
KR (1) KR0167761B1 (lv)
AT (1) ATE131534T1 (lv)
AU (1) AU631662B2 (lv)
CA (1) CA2020656C (lv)
DD (1) DD298426A5 (lv)
DE (2) DE4020438A1 (lv)
DK (1) DK0408945T3 (lv)
ES (1) ES2083399T3 (lv)
FI (1) FI102386B1 (lv)
GR (1) GR3019294T3 (lv)
HK (1) HK1005193A1 (lv)
HR (1) HRP920596B1 (lv)
HU (1) HU214243B (lv)
IE (1) IE901849A1 (lv)
IL (1) IL94529A (lv)
LT (1) LT3611B (lv)
LV (1) LV10120B (lv)
MT (1) MTP1063B (lv)
NO (1) NO304952B1 (lv)
NZ (1) NZ234542A (lv)
PL (1) PL166199B1 (lv)
PT (1) PT94776B (lv)
RU (1) RU2073720C1 (lv)
SI (1) SI9011347B (lv)
SK (1) SK280028B6 (lv)
YU (1) YU48371B (lv)
ZA (1) ZA904006B (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2067226A1 (lv) * 1969-11-27 1971-08-20 Cefilac
DE4101736A1 (de) * 1991-01-22 1992-07-23 Gruenenthal Gmbh Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
KR100467034B1 (ko) * 1996-12-27 2006-04-07 주식회사 엘지생활건강 압축성형타입오일케익화장료및그의제조방법
KR100372233B1 (ko) * 1997-03-12 2003-06-11 주식회사 코리아나화장품 미백 파우더, 그의 제조방법 및 그를 함유하는 메이크업 미백 화장료
KR100341638B1 (ko) * 2000-03-17 2002-06-22 유상옥,송운한 기능성 표면처리 분체의 제조 방법 및 이를 함유하는메이크업 화장료 조성물
JP4124639B2 (ja) * 2002-12-17 2008-07-23 株式会社日本触媒 大腸菌を用いたs−ヒドロキシニトリルリアーゼの製造方法
US7906276B2 (en) * 2004-06-30 2011-03-15 Kimberly-Clark Worldwide, Inc. Enzymatic detection techniques
EP2147105B1 (en) 2007-05-02 2013-04-24 Merial Limited Dna plasmids having improved expression and stability
RU2553533C2 (ru) * 2013-10-23 2015-06-20 Общество с ограниченной ответственностью "Международный биотехнологический центр "Генериум" ("МБЦ "Генериум") Способ выделения и очистки рекомбинантной человеческой проурокиназы м5
CN104555732A (zh) * 2015-01-18 2015-04-29 河南省中原起重机械总厂 一种多功能门式起重机

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
FI88932C (fi) * 1982-04-15 1993-07-26 Genentech Inc Framstaellning av funktionellt maenskligt urokinasprotein
US4710464A (en) * 1984-09-27 1987-12-01 Eli Lilly And Company Transcription terminators
EP0210279B1 (en) * 1985-01-25 1991-08-14 Sagami Chemical Research Center Stabilized human prourokinase
FR2594845B1 (fr) * 1986-02-21 1989-12-01 Genetica Preparation par voie microbiologique de l'activateur tissulaire humain du plasminogene (t-pa) et conversion de l'enzyme ainsi obtenue en sa forme active
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
EP0303028A1 (en) * 1987-08-10 1989-02-15 GRUPPO LEPETIT S.p.A. Method for preparing single chain urokinase
JP2970811B2 (ja) * 1987-10-30 1999-11-02 オンコゲン ア リミテッド パートナーシップ 原核生物細胞中にポリペプチドを調製するための発現システム

Also Published As

Publication number Publication date
KR910003105A (ko) 1991-02-26
MTP1063B (en) 1991-04-08
PT94776B (pt) 1997-09-30
DD298426A5 (de) 1992-02-20
NO902720D0 (no) 1990-06-19
SK306790A3 (en) 1999-07-12
NO304952B1 (no) 1999-03-08
HRP920596A2 (en) 1998-06-30
HU903970D0 (en) 1990-11-28
DE4020438A1 (de) 1991-01-31
LT3611B (en) 1995-12-27
JPH0365189A (ja) 1991-03-20
FI102386B (fi) 1998-11-30
IL94529A0 (en) 1991-03-10
NZ234542A (en) 1991-09-25
PT94776A (pt) 1991-03-20
SI9011347A (sl) 1998-04-30
FI102386B1 (fi) 1998-11-30
ES2083399T3 (es) 1996-04-16
CA2020656A1 (en) 1991-01-20
KR0167761B1 (ko) 1999-01-15
HUT54211A (en) 1991-01-28
DK0408945T3 (da) 1996-04-09
IL94529A (en) 1997-11-20
PL286087A1 (en) 1991-03-11
DE59009961D1 (de) 1996-01-25
AU5883290A (en) 1991-01-24
JP3236284B2 (ja) 2001-12-10
YU134790A (sh) 1992-12-21
RU2073720C1 (ru) 1997-02-20
SI9011347B (sl) 1999-02-28
LTIP776A (en) 1995-01-31
HK1005193A1 (en) 1998-12-24
EP0408945B1 (de) 1995-12-13
CA2020656C (en) 2001-05-22
ZA904006B (en) 1991-03-27
PL166199B1 (pl) 1995-04-28
US5637503A (en) 1997-06-10
ATE131534T1 (de) 1995-12-15
IE901849A1 (en) 1991-06-19
GR3019294T3 (en) 1996-06-30
EP0408945A1 (de) 1991-01-23
SK280028B6 (sk) 1999-07-12
NO902720L (no) 1991-01-21
AU631662B2 (en) 1992-12-03
LV10120A (lv) 1994-05-10
HRP920596B1 (en) 1999-12-31
HU214243B (hu) 1998-03-02
YU48371B (sh) 1998-07-10
FI903640A0 (fi) 1990-07-18

Similar Documents

Publication Publication Date Title
LV10120B (en) Method of producing of new plasmides and using thereof in producing of the plasminogen activator
Hülter et al. An evolutionary perspective on plasmid lifestyle modes
Hmelo et al. Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange
Xie et al. Cloning-independent and counterselectable markerless mutagenesis system in Streptococcus mutans
Komano et al. The transfer region of IncI1 plasmid R64: similarities between R64 tra and Legionella icm/dot genes
Skorupski et al. Positive selection vectors for allelic exchange
JP3654648B2 (ja) クローニング及び/または配列ベクター
Mandecki et al. FokI method of gene synthesis
Actis et al. Bacterial plasmids: replication of extrachromosomal genetic elements encoding resistance to antimicrobial compounds
EP1075512B1 (en) Cytotoxin-based biological containment
Günter et al. In vivo evidence for FhuA outer membrane receptor interaction with the TonB inner membrane protein of Escherichia coli
Matsubara Replication control system in lambda dv
KR20010071226A (ko) 이형이중나선 돌연변이성 벡터 및 박테리아에 이를이용하는 방법
HU197940B (en) Process for producing protein products by means of transformed bacteria
Miles et al. Investigation of the mechanism of active site coupling in the pyruvate dehydrogenase multienzyme complex of Escherichia coli by protein engineering
KR20210016330A (ko) 생산성이 향상된 바이러스 및 비-바이러스 나노 플라스미드 벡터
Chiang et al. Stability of pBR322-derived plasmids
Honda et al. Functional division and reconstruction of a plasmid replication origin: molecular dissection of the oriV of the broad-host-range plasmid RSF1010.
TW201111504A (en) Vector comprising mannose promoter and mannose promoter
Kreiss et al. Production of a new DNA vehicle for gene transfer using site-specific recombination
Harms et al. Identification of a two‐component regulatory system controlling methanol dehydrogenase synthesis in Paracoccus denitrificans
US8877502B2 (en) Plasmid curing
JPH07102136B2 (ja) 組換えdna、その製法、真核性又は原核性代謝産物及び遺伝子工学的に製造した蛋白質の獲得法
CY1110458T1 (el) Παραγωγα βενγαμιδης και η χρηση τους στην αγωγη καρκινικων παθησεων
Kozlowski et al. Isolation and structure of the replicon of the promiscuous plasmid pCU1